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ABSTRACT
Diabetes Group Medical Visits and Biophysical Outcomes of Care in Uninsured Persons with
Diabetes
Jennifer A Mallow
Background: Rural populations with low socioeconomic status are at higher risk of late
diabetes diagnosis, poor diabetes control, decreased self-management, and development of
complications. Diabetes Group Medical Visits (DGMVs) have been used to improve outcomes
for persons with diabetes. A gap in the literature exists related to the effectiveness of DGMVs for
uninsured persons with diabetes.
Aims: The aims of the study were to describe the characteristics of uninsured persons with
diabetes cared for in a free clinic, describe the biophysical outcomes of care, explore the
differences in biophysical outcomes of care before and after attending DGMVs versus receiving
usual care, and explore the impact of dose of DGMVs on biophysical outcomes of care.
Methods: This retrospective study was conducted at a free clinic in West Virginia, using chart
review of a convenience sample of patients following approval of the WVU IRB. The inclusion
criteria were: 1) age > 18 years, 2) diagnosis of diabetes, 3) uninsured and received care at a free
clinic between May 2007 and August 18, 2009. A total of 111 patients were studied. There were
53 participants who attended DGMVs and 58 participants who received usual care. Statistical
Package of Social Sciences (SPSS), version 18 was used for analysis of the data.
Results: The majority of the patients were female, white, severely obese, had a high-school
education or less, were age 50 or younger, had a mean of 5 co-morbid conditions other than
diabetes, and drove long distances to receive care. The patients who attended DGMVs had a
higher HgA1C, reported more pain, had increased depression levels and were more obese at
baseline than those who received usual care. There was a statistically significant decrease in

systolic blood pressure from time one to time two in patients who attended DGMVs. There was
no significant impact on biophysical outcomes of care in patients who received usual care from
time one to time two. Dose of DGMVs did not impact biophysical outcomes of care.
Conclusion: DGMV as an intervention is not enough to improve biophysical outcomes in this
population. Interventions targeted to the unique characteristics of this population are needed to
prevent devastating complications.
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CHAPTER 1: INTRODUCTION
Diabetes mellitus is one of the major causes of morbidity and mortality in the United
States with 1.6 million new cases diagnosed in people 20 years or older every year (Centers for
Disease Control, 2007). If poorly managed, diabetes increases an individual’s risk of lifelong
health complications including blindness, chronic kidney disease, lower-limb amputations,
peripheral neuropathy, decreased quality of life, decreased functional status, and emotional
distress (Prevention, 2007). In 2007, the Centers for Disease Control estimated that diabetes cost
the United States $174 billion in both direct and indirect medical costs (Centers for Disease
Control, 2007). It is estimated that nearly 23.6 million people have diabetes in the United States
(Centers for Disease Control, 2007).
Data collected from the 2008 Behavioral Risk Factor Surveillance System (BRFSS)
indicate that 14.7 percent of Americans are uninsured (Prevention, 2007). According to the 2006
National Health Information Survey (NHIS), 16.5% of persons with diabetes reported that they
needed medical care and did not receive it due to cost. Uninsured adults with diabetes
predominantly have low incomes, are members of minority groups, and receive fewer preventive
services than those with health insurance (Ayanian, Weissman, Schneider, Ginsburg, &
Zaslavsky, 2000). Hence, diabetes is a significant problem for the uninsured because untreated
diabetes can lead to devastating consequences.
Diabetes mellitus accounts for a significant proportion of the care provided by primary
health care providers (Mazze RS, 1994). Due to the complexities of managing diabetes, the
American Diabetes Association (ADA) offers a foundation by which providers direct their
medical treatment. Despite increasing provider knowledge, advancing treatment options, and
providing countless educational programs, adherence to treatment regimens continue to be less
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than optimal (SERVICES, Prevention, & Statistics, 2008). The treatment of diabetes is
dependent not only upon knowledge and awareness of the provider, but on the knowledge,
awareness, and situation of the patient (Barud, Marcy, Armor, Chonlahan, & Beach, 2006).
Current theoretically based research supports that provider approach is a key component
affecting diabetes management. However, research supports that patient education,
socioeconomic factors, and amount of social support may also affect diabetes management
(Maddigan, Majumdar, & Johnson, 2005). Substantial expenditure of healthcare dollars is
incurred by people with diabetes. Resources could be saved by a reduction in diabetes comorbidities and complications. Reduction in resource use could be accomplished through
improved diabetes care and outcomes. Cost-effective programs need to be initiated to maximize
health gains for patients and to reverse the advance of this epidemic in society (Ryan, 2009).
Specifically, peer support has been suggested to have the potential to provide a culturally
appropriate exchange of resources between patients, aimed at increasing the well-being of the
recipient of care (van Dam et al., 2005). Group medical visits, a type of peer support, have been
used in recent years to improve the process of providing care and to improve outcomes for
patients. However, there is a considerable gap in current knowledge about the effectiveness of
Diabetes Group Medical Visits (DGMVs) especially related to the dose of visits needed to
impact outcomes.
Significance
DGMVs have the potential to positively affect outcomes of care for those who are uninsured
(Clancy, Brown, Magruder, & Huang, 2003; Trento et al., 2002; Wagner et al., 2001). Little is known
about the characteristics of uninsured persons with diabetes, who attend or will benefit from group
visits, and the dosage of group visits that is needed to affect outcomes of care. Group visits may
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offer more intensive care to uninsured individuals by clustering care and providing peer support
during the visit.
Patients have reported that group visits are an acceptable form of health care, and
minority populations have found that group visits are culturally relevant (Keyserling et al.,
2000). Research has documented that persons with diabetes who participate in group visits had
increased satisfaction with care, interaction with providers, diabetes knowledge, education,
quality of life, preventive procedures and screenings (Wagner et al., 2001; Trento et al., 2001).
Clinical outcomes associated with group visits in persons with diabetes have been documented to
include: decreased or stable HgA1C, decreased cardiovascular risk, decreased or stable BMI,
decreased LDL, increased HDL, decreased or stable blood pressure and slowed progression of
retinopathy (Wagner, et al., 2001). All of these positive clinical outcomes were achieved with an
increase in provider trust and a decrease in or more effective use of provider time (Clancy et al.,
2003). However, the dosage of DGMVs that may affect outcomes of care is unknown.
This proposed study will attempt to increase knowledge related to the effect of DGMVs on

those who are uninsured, the dosage of DGMVs that may affect outcomes of care, and how
biophysical outcomes of care are impacted by DGMVs. This knowledge can potentially impact
practice, resource utilization, and research for the future.
Aims
The purpose of this descriptive, correlational study was to analyze the relationship
between attendance at Diabetes Group Medical Visits (DGMV) and biophysical outcomes of
care in uninsured persons with diabetes who are cared for in a free clinic. Specifically the aims of
this study will be:
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1. To describe the characteristics of uninsured persons with diabetes who are cared for in a
free clinic.
2. To describe the biophysical outcomes of care in uninsured persons with diabetes who are
cared for in a free clinic.
3. To compare biophysical outcomes of care in persons with diabetes before attending
DGMVs and one year after attending DGMVs.
4. To compare biophysical outcomes of care in uninsured persons with diabetes who receive
usual care in a free clinic at baseline and after one year.
5. To analyze the differences in biophysical outcomes in persons with diabetes who attend
DGMVs versus those who receive usual care in a free clinic at base line and then again
after one year.
6. To analyze the differences in characteristics of uninsured persons with diabetes who are
attendees of DGMVs versus those who receive usual care.
7. To explore the impact of dose of DGMVs on biophysical outcomes of care in uninsured
persons with diabetes who receive care in a free clinic after one year.

5
CHAPTER 2: REVIEW OF LITERATURE
The purpose of this chapter is to explore the literature related to Diabetes Group Medical
Visits (DGMVs) and biophysical outcomes of care. First, the Quality Health Outcomes Model
(QHOM), the theoretical framework guiding this study, will be presented. Then, the QHOM will
be used as a guide to present the current empirical literature related to DGMVs and biophysical
outcomes of care for persons with diabetes.
Conceptual Framework: Quality Health Outcomes Model
The theoretical framework guiding this study is the Quality Health Outcomes Model
(QHOM). The QHOM was developed by the American Academy of Nursing’s Expert Panel on
Quality Health Care in 1996 as an expansion of Donabedian’s structure-process-outcome
framework. The QHOM is a more dynamic framework that acknowledges the feedback that
occurs between patients, the system or context in which care is provided, and interventions
(Mitchell, Ferketich, & Jennings, 1998). This model links outcomes to the interactions of
patients and the healthcare system with healthcare interventions intended to treat the individual,
family, or community (Mitchell, Heinrich, Moritz, & Hinshaw, 1997). The four major concepts
included in this model are: system, interventions, patients, and outcomes. These concepts have
reciprocal connections, except for interventions and outcomes. Factors that may affect patient
outcomes include the three major concepts of the QHOM: system, interventions, and patient
characteristics (see Figure 1). Interventions affect and are affected by both system and patient
characteristics in producing desired outcomes.
The QHOM guides the identification of factors contributing to patient outcomes, which is
the focus of this study. The model posits that outcome measures are the result of care structures
that integrate functional, social, psychological, physical and physiologic aspects of people’s
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experience in health and illness. The model further proposes that such outcome measures should
be operationalized in five categories: achievement of appropriate self-care, demonstration of
health-promoting behaviors, health-related quality of life, perception of being well-cared-for, and
symptom management (Mitchell, et al., 1998).
The purpose of this study was to analyze the relationship between attendance at Diabetes
Group Medical Visits (DGMVs) and biophysical outcomes of care in uninsured persons with
diabetes who are cared for in a free clinic. The QHOM is used as the theoretical underpinning for
this study. Therefore, the literature will be reviewed and presented by the major concepts of the
QHOM: intervention, patient characteristics, and outcomes of care.
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Figure 1: Quality Health Outcomes Model

(Mitchell, et al., 1998)
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Literature Review
In this section the empirical literature related to DGMVs will be reviewed. In order to
complete the review, three computerized databases (Pubmed, Medline, and CINAHL) were
searched using the key words of diabetes, peer support, social support, support groups, group
visits, quality health outcome model, chronic care model, cooperative health care clinics, and
drop-in group medical appointments. Limits were set for articles published in the English
language. A total of 624 articles were identified that met these requirements. Group medical
visits have only emerged as a treatment option for persons with diabetes over the past decade.
Hence, limits were set for articles published in the last ten years. Limits for empirical literature in
outpatient settings were also added. In addition, the bibliographies of these studies, as well as
review articles on adherence, were examined for additional references. Review articles,
editorials, and practice models were not included. Using these limits a total of 37 articles were
reviewed. The quality of the articles was evaluated by using the Rosswurm & Larrabee critique
guidelines (Rosswurm & Larrabee, 1999). The data abstraction was completed systematically by
the author using a matrix system.
System Characteristics
System characteristics are traditional structure and process elements of organizations,
such as size, ownership, skill mix, and technology. There are three levels of system
characteristics including individual, group, and organizational levels. The system characteristics
in the QHOM are considered to directly affect and be affected by patient outcomes. The system
characteristics are the mediators of patient characteristics and interventions in producing patient
outcomes (Mitchell, et al., 1998).
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The system of interest in this study is the free clinic. The National Association of Free
Clinics defines a free clinic as a volunteer-based, safety-net health care organization that
provides a range of medical and/or behavioral health services to economically disadvantaged
uninsured individuals. Free clinics serve mostly nonelderly adults, women, and minorities with
low incomes(Darnell, 2010). There are over 1000 free clinics in the United States that provided
care for 1.8 million individuals (Darnell, 2010). Free clinics focus on providing services less
readily available to those without insurance such as medications and health education (Darnell).
Intervention
The intervention of interest in this study is the diabetes group medical visit. Mitchel et al,
(1998) posit that clinical processes, such as delivering care thorough a DGMV, are direct and
indirect interventions, however there is no single, direct connection linking interventions and
outcomes. The model suggests a reciprocal direction of influence. Interventions affect and are
affected by both system and patient characteristics in producing desired outcomes. The effect of
an intervention is mediated by the patient and the system characteristics.
Group Medical Visits
A group medical visit is defined as any visit that attempts to provide group education
while providing health care at the same time (Bray, 2005). This differs from group diabetes
education where patients may receive group education but do not receive health care. Studies
reviewed focused on DGMVs as an intervention and evaluated non-biophysical outcomes such
as feasibility, cultural relevance, acceptability, efficacy, perceptions of care, self-care behaviors,
trust in provider, cost, patient satisfaction, receipt of preventative services, quality of life,
knowledge, locus of control, and self-management support.

10
A descriptive study was published by Keyserling et al. (2000) with the purpose of
examining the feasibility of an intervention program which included group medical visits
designed to improve dietary physical activity, and self-care behaviors of older African American
women with diabetes. The sample consisted of 200 African American women with diabetes.
Focus groups were conducted to determine the cultural relevance and acceptability of the
intervention. The authors report that the participants found group visits to be culturally relevant
and acceptable. The effect of group visits on diet, physical activity, and self-care behaviors were
not studied. The feasibility of group visits as an intervention is supported by a study conducted
by Clancy, Cope, Magruder, Huang, Salter et al. (2003). The purpose of their experimental study
was to evaluate the feasibility and acceptability of group visits to uninsured or inadequately
insured patients with uncontrolled diabetes. Participants were predominantly African American
(77.5%) and most of the participants had health-care insurance (73.1%). Clancy and colleagues
(2003) found group visits to be feasible and acceptable to patients with uncontrolled diabetes
and fostered an improved sense of trust in their physician. More recently, a descriptive study was
published by Barud, Marcy, Armor, Chonlahan, & Beach (2006). The authors evaluated the
effectiveness of group medical visits for persons with diabetes in one family medicine center.
The effectiveness of the group visits was evaluated by a 12-question patient satisfaction survey
completed at the close of each group session. The survey was used to evaluate patient
satisfaction with the experience at the center. Participants reported that group visits helped
clinicians provide them with more efficient health-care and education than traditional care. Not
only have group visits been found to provide more efficient care, they have also been shown to
increase positive perceptions of health-care. Clancy, Yeager, Huang, & Magruder (2007)
conducted a study to evaluate perceptions of care delivered through group visits to disadvantaged
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patients with diabetes. The design of the study was experimental. A total of 120 persons with
diabetes were randomly assigned to receive their care in group visits or usual care for six
months. After six months, patient satisfaction was measured by survey. The sample was 72 %
female and 82% African American. The authors reported that patients assigned to group visits
had generally more positive perceptions about their care in the areas of ongoing care, community
orientation of care, and cultural competence of care than did those in usual care. However, one
study did find that telephone management of diabetes may be better for some patients.
Schillinger et al. (2007) attempted to describe the difference in self-management support systems
in the dimensions of participation, representativeness and engagement between group visit
participants and patients receiving individual support through telephone disease management.
The study found that telephone disease management yielded higher engagement, especially
among those with limited English proficiency and limited literacy. However, no statistical testing
for differences in engagement between telephone disease management and group medical visits
was performed. In summary, this literature review supports that DGMVs have the potential to
impact outcomes of care.
Outcomes of Care
An outcome is said to be a component of a patient’s clinical and functional status after an
intervention has been applied (Barr, Schumacher, & Myers, 2001). The QHOM proposes that
outcome measures should be the result of care structures and processes that integrate functional,
social, psychological, physical, and physiologic aspects of people’s experience in health and
illness (Mitchell et al., 1998). Studies reviewed evaluated common outcomes measured in
diabetes populations outcomes of care such as HgA1C, weight, blood pressure, fasting glucose,
lipids, hypoglycemic episodes, anxiety, depression , end organ damage, and microalbumin
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(Clancy, Brown, et al., 2003; Clancy, Yeager, Huang, & Magruder, 2007; Culhane-Pera et al.,
2005; Trento, et al., 2002; Trento et al., 2001; Wagner, et al., 2001). Additionally, some studies
evaluated both biophysical outcomes as well as non-biophysical outcomes of care.
Biophysical Outcomes of Care
While HgA1C is commonly used to determine an improvement in glucose levels in
persons with diabetes, multiple other outcomes measures can be used as indicators of improved
care. Trento et al. (2002) published the results of a randomized controlled clinical trial to
compare traditional individual diabetes care with a model in which routine follow-up was
managed by interactive group visits. The study found that HgA1C increased in the usual care
group but not in the group visit patients; those participating in group visits had a decrease in their
BMI and an increase in HDL. In addition, the dosage of hypoglycemic agents decreased and
retinopathy progressed less among the group care patients. Diastolic blood pressure and relative
cardiovascular risk decreased from baseline in both the group visit and usual care patients. More
biophysical outcomes of care were looked at by Kirsh et al. (2007). The purpose of the study by
Kirsh and colleagues (2007) was to evaluate the impact of shared medical appointments on
intermediate outcome measure of care for persons with diabetes focusing on those patients at
highest cardiovascular risk. Chart reviews were conducted to collect data. The findings suggested
that reductions in HgA1C, LDL, and systolic blood pressure were greater in the intervention
group but the difference was not statistically significant. Another study which looked at only
biophysical outcomes had similar findings. A quasi-experimental study published by Bray,
Thompson, Wynn, Cummings, & Whetstone (2005) explored the efficacy of combining care
management and interdisciplinary group visits for rural African American persons with diabetes
mellitus. The vast majority of participants were African American (90%). Most patients had
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health insurance through Medicare or Medicaid (83%). The intervention group had a significant
decrease in HgA1C versus the control group compared over the same time period. No significant
differences in mean weight or blood pressure between group visits and usual care were found.
Biophysical Outcomes & Diabetes Group Medical Visits as an Intervention
Biophysical outcomes do not always improve when using DGMVs as an intervention.
Clancy, Cope, Magruder, Huang, & Wolfman (2003) published results of an experimental study
to evaluate the effectiveness of a managed care approach to health care delivery, i.e. group visits,
in the management of uninsured or inadequately insured patients with diabetes. The participants
were predominantly female (78.3%) and African American (77.5%). Most of the participants had
health-care insurance (73.1%). The data collected were those charted as ADA standards of care:
HgA1C and lipids over 6 months. Group visits were found to be more effective in promoting
documentation of concordance with ADA standards of care than usual care. However despite the
innovative delivery method, there were no significant differences seen in diabetes or lipid
control. Five years later, Clancy, Huang, Okonofua, Yeager, & Magruder (2007) published a
study with similar findings. The study evaluated the effect of group visits on documentation of
clinical outcomes in concordance with 10 American Diabetes Association guidelines. The study
was an experimental design with measures of ADA standards of care at 6 and 12 month
intervals. The sample consisted of 186 patients with diabetes, predominantly female (72 %)
and African American (82%). Findings of the study at both measurement points were that
HgA1C, blood pressure, and lipid levels did not differ significantly for patients attending group
visits versus those receiving usual care. At 12 months, patients in group visits exhibited greater
concordance with ADA process of care indicators and rates for cancer screening patients. The
authors suggest that modification to the content and style of group visits may be necessary to
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achieve improved clinical outcomes. Another study that measured biophysical and nonbiophysical outcomes of care had comparable results. Culhane-Pera et al. (2005) published the
results of a study with the purpose of evaluating the influence of group visits on diabetes
management in Hmong adults with diabetes. The hypothesis of this study was that group visits
would improve diabetes management. The authors reasoned that having a forum to discuss
diabetes in a culturally familiar group setting would facilitate people’s acceptance of clinical
services, medications, and lifestyle changes. The study findings were that participants received
better services; however, biological parameters and mental health did not improve.
One study has shown positive effects of group visits for both biophysical and nonbiophysical outcomes of care. Wagner et al. (2001) published the results of a quasi-experimental
study with 707 diabetes patients. The purpose of the study was to evaluate the impact of primary
care group visits on the process and outcome of care for diabetic patients. The findings of the
study showed the intervention group had received significantly more recommended preventive
procedures and patient education. There was a consistently positive association between the
number of group visits attended and outcomes, such as patient satisfaction and HgA1C levels.
Cost can also be decreased through implementation of group visits. Bray, Roupe et al.
(2005) conducted a study to assess the feasibility and potential for cost effectiveness of
restructuring care in rural fee-for-service practices for predominantly minority persons with
diabetes. The majority of patients were African American (72%) and more than half of the
patients were female (54%). The major findings of the study were an improvement in the
percentage of patients achieving diabetes management goals. Additionally, there was
improvement in the providers’ productivity and billable encounters. Increased monetary revenue
can be accompanied by decreasing workloads of providers. Trento et al. (2001) conducted a
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study to evaluate whether group visits in diabetes care are more effective than individual
consultations in improving self-care and metabolic control. The hypothesis of their quasiexperimental study was that individual visits could be merged with interactive group visits into a
permanent therapeutic educational process, including interactive techniques, positive group
dynamics and identification with other group members, without increasing the workloads of
health care providers in outpatient diabetes care. The authors reported that participants in group
consultations had stable HgA1C levels as compared to increased HgA1C levels in control group.
The intervention group had lower cardiovascular risk scores, improved diabetes knowledge,
better quality of life, improved health behavior scores and longer interaction with health-care
providers, while the physicians spent less time seeing the group rather than completing
individual appointments.
Diabetes group medical visits have been studied in various patient populations and
numerous disciplines. Both qualitative and quantitative designs have been used to study this
model for care. Qualitatively, researchers have studied diabetes group medical visits though
interviews usually focusing on quality of life. Typically, in quantitative studies, health outcomes
are measured to determine effectiveness of group visits. The outcomes measured vary from study
to study. Frequently, studies that use group medical visits as an intervention, measure outcomes
of adherence such as body mass index, weight, glycosylated hemoglobin, fasting blood glucose,
blood creatinine, lipids, microalbuminuria, blood pressure, evidence of end organ damage,
depression, anxiety, medication use, and foot care. Other studies evaluated process of care
indicators such as prescribed ACE inhibitors, aspirin, cholesterol management, cholesterol
treatment, measurement of glycosylated hemoglobin, measurement of microalbumin,
Pneumovax administration, influenza vaccine administration, eye examination, and foot
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examination (Chiu et al., 2009; Clancy, Brown, et al., 2003; Clancy, Yeager, et al., 2007;
Culhane-Pera, et al., 2005; Guzek, Guzek, Murphy, Gallacher, & Lesneski, 2009; Trento, et al.,
2002; Trento, et al., 2001; Wagner, et al., 2001). Yet other studies have measured system
characteristics such as the cost effectiveness, productivity and billable encounters of diabetes
group medical visits (Bray et al., 2005; Clancy, Brown, et al., 2003; Clancy, Dismuke,
Magruder, Simpson, & Bradford, 2008). Other than HgA1C, no two researchers found in this
review, measured the same outcomes of care in persons with diabetes who received group
medical visits or used the same measurement tools. The literature supported outcome measures
that were used for the proposed study include body weight, body mass index, fasting blood
glucose, HgA1c, serum creatinine, lipids, blood pressure and microalbumin.
Patient Characteristics
Mitchell and colleagues (1998) state that patient characteristics are factors that directly
affect outcomes and include client health, demographics, and disease risk factors. Age, gender,
ethnicity, marital status, duration of diabetes, education, distance from clinic, co-morbidities, and
depression are all patient characteristics commonly measured in diabetes group medical visits
(Barud, et al., 2006; Bray, Roupe, et al., 2005; Bray, Thompson, Wynn, Cummings, &
Whetstone, 2005; Clancy, Brown, et al., 2003; Clancy, et al., 2008; Clancy, Yeager, et al., 2007;
Culhane-Pera, et al., 2005; Keyserling, et al., 2000; Schillinger et al., 2007; Trento, et al., 2002).
Examining patient characteristics may identify which patient populations for which DGMVs are
most beneficial.
Age
Age of patients has been associated with self-management activities, thus affecting
outcomes of care. The World Health Organization (2003) reports that in most studies of
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adherence, age of the patient was associated with outcomes of care (Sabate, World Health,
Project, & Global Adherence Interdisciplinary, 2003). Leventhal et. al, (2001) reported that
compared to younger participants, persons with diabetes over the age of 25 reported exercising
on fewer days per week, and spending less time in recreational physical activities. Older adults
may also practice better self-management than younger adults (Leventhal H, 2001). Additionally,
the fact that glucose intolerance increases with age has been apparent for over 30 years (Andres,
1971).
Ethnicity
Other patient characteristics such as ethnicity can affect outcomes as well. The rate of
diabetes is increasing fastest in ethnic minorities, including African Americans, Mexican
Americans, and Native Americans (Promotion, Accessed September 20, 2010). Because of
cultural differences, ethnicity is reported to be a risk factor for poorer quality in health care,
disease management and disease control. Ethnic minority groups are at risk for poorer quality of
life and increased disease complications when compared with non-ethnic counterparts living in
the same country (Mc Manus & Savage). Mitchell and colleagues (1998) suggested that client
characteristics, such as ethnicity have a meaningful, direct effect on behavioral and health status
outcomes. It is believed that clients live in a social environment with cultural values and beliefs
about health and healthcare (Mitchell, et al., 1998). These values and beliefs affect the patients’
desire to interact and ability to interact with a care delivery system (Holzemer, 1994).
Comorbidities
The majority of older adults have two or more chronic conditions and among patients
with diabetes, 40% have at least three (Sabate, et al., 2003). Patients with a greater overall
number of comorbidities place lower priority on diabetes and have worse diabetes self-
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management ability scores (Glasgow, Toobert, & Hampson, 1996). The type and severity of
comorbid conditions can affect outcomes of care. Patients with severely symptomatic
comorbidities and those with conditions they consider to be unrelated to diabetes may need
additional support in making decisions about care priorities and self-management activities (Kerr
et al., 2007).
One co-morbidity that may affect outcomes of care in persons with diabetes is
depression. The incidence of depression has been observed to be twice as high among persons
with diabetes than in the general population (J. J. Prochaska, Nigg, Spring, Velicer, &
Prochaska). Patients with depression are more likely to experience complications of diabetes,
have worse glycemic control, and be less adherent to self-care behaviors than patients who are
not depressed (J. O. Prochaska, 2008).
Other Patient Characteristics
Other patient characteristics such as gender, duration of diabetes, miles to clinic, and
educational level also are suggested to affect outcomes of care. Gender has been associated with
outcomes such that men with diabetes have been found to be more physically active than women
with diabetes, but they also consume more calories, eat more inappropriate foods and have lower
levels of adherence (Whitlock, Vogt, Hollis, & Lichtenstein, 1997). Duration of disease appears
to have a negative relationship with adherence: the longer a patient has had diabetes, the less
likely he or she is to be adherent to treatment (Glasgow, Davidson, Dobkin, Ockene, & Spring,
2006). Longer driving distances from home to the site of primary care were associated with
poorer glycemic control in older, rural subjects (Strauss, MacLean, Troy, & Littenberg, 2006).
Educational level has been shown to be significant in disease control of diabetes patients. On the
National Health and Nutrition Examination Survey from 1999 to 2006 those persons with
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diabetes who are more educated have consistently shown an improved HgA1C, blood pressure
and total cholesterol level than those who are less educated (McWilliams, Meara, Zaslavsky, &
Ayanian, 2009). Education level and health literacy also appear to have an effect on participation
in medical decision making and thus may impact outcomes of care (DeWalt, Boone, & Pignone,
2007). Patient characteristics that will be examined in the proposed study are therefore, age,
gender, ethnicity, marital status, duration of diabetes, education miles form clinic, comorbidity,
and depression.
Synthesis
Group visits for persons with diabetes have been found to be feasible (Keyserling, et al.,
2000). This practice change has been implemented in a variety of clinical systems. Patients have
reported that group visits are an acceptable form of health care, and minority populations find
that group visits are culturally relevant (Keyserling, et al., 2000).
Feasibility, cultural relevance, acceptability, trust in provider, cost, self-management
support, perceptions of care, satisfaction, receipt of preventive services, insurance status, and
efficacy have been studied while providing DGMVs as an intervention. The outcomes of care
that have been studied with DGMVs are HgA1C, weight, blood pressure, fasting glucose, lipids,
hypoglycemic episodes, anxiety, depression, end organ damage, microalbumin, self-care
behaviors, patient quality of life, knowledge, ethnicity, and locus of control. Patient
characteristics commonly studied in relation to DGMVs have been age, gender, ethnicity, marital
status, duration of DM, education, miles from clinic, co-morbidities and depression.
Research documented that persons with diabetes who participate in group visits as an
intervention experience an increase in the following: satisfaction with care, interaction with
providers, diabetes knowledge, education, quality of life and preventive procedures and
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screenings (Trento, et al., 2001; Wagner, et al., 2001). Clinical outcomes associated with group
visits have been documented to include: decreased or stable HgA1C, decreased cardiovascular
risk, decreased or stable BMI, decreased in LDL, increased in HDL, decreased or stable blood
pressure and slowed progression of retinopathy (Clancy, Cope, et al., 2003). Positive clinical
outcomes have been achieved with an increase in provider trust and a decrease or more effective
use of provider time (Clancy, Cope, et al., 2003). However, worsening of diabetes control is only
found to have been prevented in studies where patients had peer support and consultation with a
physical or other health care provider (Philis-Tsimikas et al., 2004; Trento, et al., 2001).
While these findings regarding group visits are promising, some major limitations in the
evidence still exist. Random assignment to treatment was rare in the studies reviewed. Because
most subjects volunteered to be involved in the treatment, selection bias may have occurred, as
highly motivated patients are more likely to volunteer. The majority of the participants in each
study were from ethnic minority groups and female. All but one study focused on participants in
their 5th and 6th decades of life. Most of the participants had some type of health care insurance.
While these studies add to the body of knowledge regarding group medical visits for persons
with diabetes, lack of randomization and lack of heterogeneity limits generalizability of the
findings.
The purpose of this study was to analyze the relationship between attendance at Diabetes
Group Medical Visits (DGMVs) and biophysical outcomes of care in uninsured persons with
diabetes who are cared for in a free clinic. The conceptualization of the QHOM for the purposes
of this study is shown in Figure 2. The system characteristic in this study was a free clinic for
those who are uninsured in North Central West Virginia. This system characteristic remained
constant for all subjects. The intervention will be Diabetes Group Medical Visits. The patient
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characteristics studied were age, gender, ethnicity, marital status, duration of DM, education,
miles from clinic, co-morbidities, and depression. The outcomes measured were body weight,
BMI, fasting blood glucose, HgA1C, creatinine, lipids, blood pressure, and microalbumin. All
outcomes were compared before and after group medical visits, as well as to a group of patients
in the same system who received traditional care.
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Figure 2: Conceptualization of QHOM for DGMVs
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Figure 3: Deconstructed Model for Proposed Study
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CHAPTER 3: METHODOLOGY
The purpose of this study was to examine the relationship between attendance at Diabetes
Group Medical Visits (DGMV) and biophysical outcomes of care in uninsured persons with
diabetes who receive care in a free clinic. Specifically the aims of this study were:
1. To describe the characteristics of uninsured persons with diabetes who are cared for in a
free clinic.
2. To describe the biophysical outcomes of care in uninsured persons with diabetes who are
cared for in a free clinic.
3. To compare biophysical outcomes of care in persons with diabetes before attending
DGMVs and one year after attending DGMVs.
4. To compare biophysical outcomes of care in uninsured persons with diabetes who receive
usual care in a free clinic at baseline and after one year.
5. To analyze the differences in biophysical outcomes in persons with diabetes who attend
DGMVs versus those who receive usual care in a free clinic at base line and then again
after one year.
6. To analyze the differences in characteristics of uninsured persons with diabetes who are
attendees of DGMVs verses those who receive usual care.
7. To explore the impact of dose of DGMVs on biophysical outcomes of care in uninsured
persons with diabetes who receive care in a free clinic after one year.
This chapter conceptually and operationally defines measures used to meet the study aims and
describes study methods.
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Variable Definitions
Diabetes Group Medical Visits
Conceptual Definition
The group medical visit model was developed in managed care to improve effectiveness
of care of patients (Clancy, Huang, Okonofua, Yeager, & Magruder, 2007). Mental health
providers and behavioral therapists have long recognized the value of groups when seeking
improved psychological and behavioral outcomes for people with chronic illnesses (Beck et al.,
1997). Group interaction appears to provide emotional support while lessening feelings of
isolation and stigmatism that are associated with some chronic illnesses (Weinger, 2003). A
group medical visit must include at least two patients, who are united in a health-related
situation, and a medical provider (Barud, et al., 2006). Each patient must share similar
experiences and be willing to participate in a group. All parties need to possess the ability to
receive and respond to social interaction. Group participants must also possess specific
knowledge derived from personal experience. All group medical visits include some degree of
information, appraisal and emotional support (Dennis, 2003). Additionally, some form of health
care provider is present. In this, group visits differ from other forms of group interventions, such
as support groups or diabetes education, which are generally led by peers and do not include oneon-one consultations with a health care provider.
Operational Definition
In the free clinic where this study took place, the DGMV was an additional health care
visit and is meant to supplement individual healthcare visits to improve patient outcomes.
Diabetes Group medical visits included group education and interaction and elements of an
individual patient visit, such as the collection of vital signs, history taking, physical exam,
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medication adjustments, appropriate standardized referrals, and laboratory procedures related to
diabetes care (Jaber, Braksmajer, & Trilling, 2006). The curriculum for this clinic’s DGMV,
which was adapted from the American Diabetes Association’s standards of care
(AmericanDiabetesAssociation, 2010) was developed by the Nurse Practitioner at the clinic in
conjunction with a Pharmacist (PharmD) who is obtaining certification in diabetes education.
The free clinic offered up to six DGMVs in which the patients were provided education about
blood glucose monitoring, medication, nutrition, exercise, foot care, heart disease, complications
including sick day care, and behavior changes. The patients were scheduled to attend the clinic
up to once a month until they had received all of the education offered by the DGMVs. Because
the classes were offered four times per month, the patients could schedule at their convenience.
Hence, the participants in each group varied from class to class. Patients were referred to the
DGMV by their primary care provider for additional care. Attendance at the DGMVs was
voluntary. Data related to the number of DGMVs were collected from the chart and was coded
1,2,3,4,5 or 6 depending on the number of visits patients experienced. Data were also collected
on which DGMVs the patient attended. The data were recorded as categorical for each of the
following DGMV categories: blood glucose monitoring, medication, nutrition, exercise, foot
care, heart disease, complications including sick day care, and behavior changes.
Usual Care
Conceptual Definition
Usual care can be defined as the routine care received by those patients who did not
participate in DGMVs. The American Diabetes Association (ADA) has built the foundation by
which providers direct their medical treatment for diabetes management. Ten established
guidelines backed by research findings have become the standard for diabetes medical
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management. Recommendations for all persons with diabetes are to have annual retinal and foot
exams, annual influenza vaccinations, and pneumococcal immunizations, and monitoring of
blood pressure, urine microalbumin levels, lipid profiles, quarterly measurement of HgA1C, and
cardiovascular risk factor assessment with treatment as indicated for all abnormal results.
Operational Definition
Usual care for persons with diabetes in the free clinic where the study took place included
collection of vital signs, history taking, physical exam, medication adjustments, appropriate
referrals, laboratory procedures, and education provided by the health care provider related to
general care. Usual care did not include education provided by a Pharm D or diabetes educator
with a group of other diabetes patients at the time of the usual care visit. Data related to the
number of care visits during the study period were collected from the chart as a continuous
variable.
Biophysical Outcomes of Care
Conceptual Definition
An outcome is said to be a component of a patient’s clinical and functional status after an
intervention has been applied (Barr, et al., 2001). Biophysics refers to the process of assigning an
objective measurement to a bodily process. For the purposes of this study, a biophysical outcome
of care was defined as the measurable result of care collected over a specific time frame.
Common biophysical outcomes measured in diabetes populations are body weight, body mass
index (BMI), glycosylated hemoglobin (HgA1C), fasting blood glucose (FBG), serum creatinine,
serum lipids, urine microalbumin, and blood pressure (Clancy, Brown, et al., 2003; Clancy,
Yeager, et al., 2007; Culhane-Pera, et al., 2005; Trento, et al., 2002; Trento, et al., 2001; Wagner,
et al., 2001).
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Operational Definition
This study collected the common biophysical outcomes measured in diabetes, body
weight, BMI, HgA1C, fasting blood glucose, serum creatinine, serum lipids, urine microalbumin,
and blood pressure.
Body Weight
Body weight was obtained routinely and recorded in the chart at the beginning of each
clinic visit. Weight was measured and recorded in pounds (lbs). The clinic used an upright
mechanical medical scale with capacity to weigh patients up to 350 lbs. This study collected the
first body weight available prior to May 2007 and the most recent body weight recorded on or
before August 18, 2009. The weight of patients that weigh more than 350 lbs is reported in the
chart as “350+.” These data were recorded and analyzed as a continuous variable.
Body Mass Index
Body mass index was calculated with the following formula: weight (lb) / [height (in)]2 x
703. Height was collected via patient report and recorded in the chart upon initial visit. Weight
was obtained routinely and recorded in the chart at the beginning of each clinic visit. This study
collected the first body weight available prior to May 2007 and the most recent body weight
recorded on or before August 18, 2009. BMI was calculated based on the initial patient reported
height. These data were entered as a continuous variable.
Glycosylated Hemoglobin
Glycosylated Hemoglobin levels were drawn as part of routine diabetes care. In this
clinic the measurement of HgA1C was performed by two separate outside laboratories. One
laboratory used the Dade Dimension technique, applying the turbidimetric inhibition
immunoassay principle, where the total hemoglobin was based on a modification of the alkaline
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hematin reaction (McMillan, 2009). The percentage of total hemoglobin that was glycated was
calculated and reported as %HgA1C. The reference range is 4.8 to 6.0%. The other laboratory
performed HgA1C testing using the BioRad Variant II system, which used ion exchange highperformance liquid chromatography (HPLC) to determine percentage of glycated hemoglobin
(Hinkle, 2009). The reference range is 4.4% to 6.8%. The American Diabetes Association (2010)
recommends that laboratories use only Glycohemoglobin assay methods that have been approved
by the National Glycohemoglobin Standardization Program. Both laboratories met these
requirements and reported results in percentage of HgA1C. While the laboratories reported
different reference ranges, both laboratories reported values in percentage of HgA1C. Hence, the
difference in laboratory testing procedures was not clinically significant and would not affect
percentage values or clinical decision making. This study collected the first HgA1C available
prior to May 2007, and the most recent HgA1C recorded on or before August 18, 2009. These
data were recorded and analyzed as a continuous variable.
Fasting Blood Glucose
Fasting blood glucose measures blood glucose after a patient has not eaten for at least 8
hours. Fasting blood glucose was self-reported by the patient and recorded in the clinic visit note.
All patients measure fasting blood glucose with a glucometer provided for home use by the free
clinic. The meter then displays the level in milligrams per deciliter. This study collected the first
fasting glucose available prior to May 2007 and the most recent fasting blood glucose recorded
on or before August 18, 2009. These data were recorded and analyzed as a continuous variable.
Serum Creatinine
A serum creatinine test measures the amount of creatinine in the blood. The test was done
to evaluate kidney function. Creatinine levels were drawn as part of routine diabetes care. In this
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clinic, the measurement of serum creatinine was performed by two separate outside laboratories.
Both laboratories reported creatinine in milligrams per deciliter. The reference range for both
laboratories is 0.5 – 1.2 milligrams per deciliter. This study collected the first serum creatinine
available prior to May 2007, and the most recent serum creatinine recorded on or before August
18, 2009. These data were recorded and analyzed as a continuous variable.
Serum Lipid levels
Serum lipid levels are considered to be any major lipid in the circulation. Serum lipid
levels were routinely collected and reported as total cholesterol, high density lipoproteins (HDL),
low density lipoproteins (LDL), and triglycerides (TG). Serum lipid levels were drawn as part of
routine diabetes care. In this clinic the measurement of serum lipid was performed by two
separate outside laboratories. Both laboratories reported serum lipids in milligrams per deciliter.
The normal reference range was equivalent in both laboratories. This study collected the first
serum lipids available prior to May 2007, and the most recent serum lipids recorded on or before
August 18, 2009. These data were recorded and analyzed as four separate continuous variables.
Urine Microalbumin
Often urine microalbumin can be an earlier sign of potential kidney disease than serum
creatinine. A urine microalbumin test measures the amount of albumin in the urine. The test was
done to evaluate kidney function. Urine microalbumin was collected as part of routine diabetes
care. In this clinic the measurement of urine microalbumin was performed by two separate
outside laboratories. Both laboratories reported urine microalbumin in milligrams per deciliter.
The normal reference range was equivalent in both laboratories. This study collected the first
urine microalbumin available prior to May 2007, and the most recent urine microalbumin
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recorded on or before August 18, 2009. These data were recorded and analyzed as a continuous
variable.
Blood Pressure
Blood pressure was obtained routinely and recorded in the chart at the beginning of each
clinic visit. Blood pressure was measured and recorded as systolic over diastolic millimeters of
mercury. The clinic used an automated blood pressure cuff. This study collected the first blood
pressure available prior after May 2007, and the most recent blood pressure recorded on or
before August 18, 2009. These data were recorded and analyzed as two separate continuous
variables.
Patient Characteristics
Patient characteristics collected were: age, gender, ethnicity, marital status, duration of
diabetes, education level, distance in miles from residence to clinic, depression score, and comorbidities.
Age
Age was collected from the chart from date of birth. Age was recorded at the age of the
first visit within the time frame for the study. These data were recorded and analyzed as a
continuous variable.
Gender
Gender was collected from the chart, and recorded as a dichotomous variable, either male
or female.
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Ethnicity
Ethnicity, recorded upon establishment of care at the clinic, was collected from the chart.
Ethnicity was collected by patient self-report. Ethnicity was recorded in the following categories:
White, African-American, Asian, Hispanic, Native American, and other.
Marital status
Marital status was collected from the chart. Marital status is asked on the initial visit and
was reassessed every year. Marital status was collected by patient self-report. The most recently
recorded marital status was collected in the following categories: single, married, divorced,
separated, widowed, significant other.
Duration of diabetes
Duration of diabetes was collected by chart review using patient self report data. Subjects
are asked to report the number of years that they have had diabetes during clinic visits. The
duration of diabetes was recorded from the beginning of the study period. Duration of diabetes
was recorded as a continuous variable.
Educational Level
Education was collected by chart review. Education was recorded in the chart upon initial
visit to the clinic. Education was recorded from the beginning of the study period in the
following categories: less than high school, graduated high school, some college, college
graduate, master’s degree, doctorate, GED.
Distance in miles from residence to clinic
Home address was recorded in the chart at the initial visit and is verified every visit.
Miles from residence to the clinic was calculated with Yahoo Map Quest using the clinic address
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and the patient address. Home address was not kept in any study data file. Miles from residence
to clinic was analyzed as a continuous variable.
Depression Score
Depression score was collected upon initial visit, using The Center for Epidemiologic
Studies Depression Scale (CES-D) (Deeb-Sossa, 2003). The CES-D is a commonly used
screening test for determining depression quotient. While the tool is not diagnostic of clinical
depression, it has been used in the past as an indicator of depression. The CES-D was filled out
by the patient and can be completed in less than five minutes at the first visit prior to receiving
care at the free clinic. While the CES-D was to be filled out yearly, it is not commonly updated
at the free clinic. Hence, it was not be measured as an outcome of care but rather as a patient
characteristic. The CES-D measured depressive feelings and behaviors during the past week.
Each question was scored using a range of zero to three points. A score of less than 15 indicated
no or few depressive feelings and behaviors during the past week. A score of 15-21 indicated
mild to moderate depression. A score of over 21 indicated the possibility of major depression.
Depression score was collected and recorded as a categorical variable.
Co-Morbidities
An ongoing list of active and prior medical conditions was kept on the medical chart. For
the purposes of this study, a co-morbidity was the diagnosis of all other chronic diseases an
individual patient might have other than diabetes. The data were recorded as a continuous
variable, reflecting the total number of co-morbidities the patient has and as a dichotomous
variable as yes/no for each of the following co-morbidities: hypertension, kidney disease,
hyperlipidemia, heart disease, depression, obesity, kidney disease, pain, eye disease, neuropathy,
and frequent infections. In order to further investigate the impact of co-morbid conditions a
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predictive index such as the Charlson co-morbidity scale was considered for use. . However, due
to the retrospective nature of this study, all data were not available to make use of the Charlson
co-morbidity index.
Sample
This retrospective study was conducted at a free clinic in West Virginia, using chart
review of a convenience sample of patients who met the inclusion criteria. This study was
approved by the Institutional Review Board of West Virginia University. The inclusion criteria
are: 1) age > 18 years, 2) diagnosis of diabetes, 3) uninsured and received care at a free clinic
during the study period. The only specific exclusion criteria would be an accidental charting of
diabetes where no diabetes exists. Two independent groups were studied, those who attended
DGMVs and those who did not attend DGMVs. To achieve a power of 0.8 considering a medium
effect size to detect a difference in means between two independent groups, a sample of 51
charts in each group was required (Calculated with G*Power 3). The significance level of
p=0.05 was used.
Data Collection
A registry of all persons with diabetes who are patients was kept by the free clinic. The
registry was reviewed by the research and clinic staff. All persons with diabetes who received
care from May 2007, when DGMVs were started at the clinic, to August 18, 2009 were
identified. The clinic underwent a change to electronic medical records throughout the year
2008. Hence, some data were obtained from previous paper medical records and current
electronic medical records. The medical records of all persons with diabetes within the study
time frame were pulled from the medical record room by the staff at the clinic. If the data were
entirely electronic, the electronic medical record was reviewed. No patient identifiers were
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collected. No information was able to be linked back to the subject. The data were extracted from
the paper medical record or electronic medical record by a medical assistant at the clinic. The
medical assistant was educated by the investigator on data collection procedures. The medical
assistant was provided with a training manual to keep in the clinic as a reference guide. The
investigator was available via phone or e-mail for additional questions. Ten percent of the charts
reviewed by the medical assistant over the first week of data collection were also reviewed by
the investigator. An inter-rater reliability of 95% accuracy between the data collected by medical
assistant and the data collected by the investigator was set and met. Identified charts were
reviewed by the investigator or medical assistant in a private setting in the clinic. Biophysical
outcomes of care were collected from the chart and recorded from two separate time periods.
Biophysical outcomes for patients who did not participate in DGMVs were collected as reported
in the chart during or after May 2007 and then again after one year. Biophysical outcomes of
care were collected from the chart of patients who did participate in DGMVs prior to the initial
DGMV and then again in one year. Data were entered into Microsoft Access for ease of use for
the medical assistant collecting the data and then were converted into Statistical Package of
Social Sciences (SPSS), version 18 for analysis of the data. Data was stored on a USB travel
drive which was and continues to be password protected. The USB travel drive was and will
continue to be kept in a locked office at the clinic or the locked office of the investigator when
not in use.
Analysis Plan
Prior to analysis, the data were cleaned, looking for outliers or impossible values. This was
accomplished by running frequencies and descriptive statistics and visually scanning for missing data
and for patterns of missing data. Any variable item that had missing data such that it decreased
power, or missing data with any identifiable pattern was not analyzed.
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Aim 1: To describe the characteristics of uninsured persons with diabetes who are cared for in a
free clinic.
To describe the characteristics of the study sample descriptive statistics was used. The
categorical variables gender, ethnicity, marital status, education, and type of co-morbidities were
analyzed using frequencies and frequency tables and were reported as percentages. The
continuous variables age, duration of diabetes, number of co-morbidities, and miles from the
clinic were analyzed using mean, median and standard deviation.
Aim2: To describe the biophysical outcomes of care in uninsured persons with diabetes who are
cared for in a free clinic.
To describe the biophysical outcomes of the study sample, descriptive statistics were
used. The continuous variables body weight, BMI, fasting blood glucose, HgA1C, creatinine,
lipids, blood pressure, and microalbumin were analyzed using mean, median and standard
deviation.
Aim 3: To compare biophysical outcomes of care in persons with diabetes before attending
DGMVs and again one year after attending DGMVs.
To compare biophysical outcomes of care in persons with diabetes before attending
DGMVs and again one year after attending DGMVs paired t-tests were used. Differences in
means of body weight, BMI, HgA1C, fasting blood glucose, serum creatinine, serum lipids,
urine microalbumin, systolic blood pressure, and diastolic blood pressure before attendance and
DGMVs were compared to means at one year after attending DGMVs. The level of measurement
for these variables was at the interval/ratio level. The data were obtained from a representative
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sample from the population. Tests for the assumptions necessary for the use of parametric
statistics, such as normal distribution and homogeneity of variance, were performed. If after
preliminary data analysis was performed, violation of assumptions was recognized, Wilcoxon
Signed Rank test was used. If no assumptions were violated, a paired t-test was used. A value of
p=0.05 was used to determine significance of the findings.
Aim 4: To compare biophysical outcomes of care in uninsured persons with diabetes who
receive usual care in a free clinic at baseline and after one year.
To compare means of biophysical outcomes of care in uninsured persons with diabetes
who receive care in a free clinic and again after one year, paired t-tests were used to look at the
difference in means of body weight, BMI, HgA1C, fasting blood glucose, serum creatinine,
serum lipids, urine microalbumin, systolic blood pressure, and diastolic blood pressure. The level
of measurement for these variables was at the interval/ratio level. The data were obtained from a
representative sample from the population. Tests for the assumptions necessary for the use of
parametric statistics, such as normal distribution of differences were performed. If after
preliminary data analysis was performed, violation of assumptions was recognized, Wilcoxon
Signed Rank test was used. If no assumptions were violated, a paired t-test was be used. A value
of p=0.05 was used to determine significance of the findings.
Aim 5: To analyze the differences in biophysical outcomes in persons with diabetes who attend
DGMVs versus those who receive usual care in a free clinic at base line and then again after one
year.
To analyze the differences in biophysical outcomes in persons with diabetes who attend
DGMVs versus those who receive usual care in a free clinic after one year, independent t-tests
were used to compare means for body weight, BMI, HgA1C, fasting blood glucose, serum

38
creatinine, serum lipids, urine microalbumin, systolic blood pressure, and diastolic blood
pressure. The level of measurement for these variables was at the interval/ratio level. The data
were obtained from a representative sample from the population. The data were independent of
one another. Tests for the assumptions necessary for the use of parametric statistics, such as
normal distribution of each population and homogeneity of variance, were performed. If after
preliminary data analysis was performed, violation of assumptions was recognized, MannWhitney U test was used. If no assumptions were violated, an independent-samples t-test was
used. A value of p=0.05 was used to determine significance of the findings.
Aim 6: To analyze the differences in characteristics of uninsured persons with diabetes who are
attendees of DGMVs versus those who receive usual care.
To analyze the differences in characteristics of uninsured persons with diabetes who
attend DGMVs versus those who receive usual care in a free clinic after one year group, means
were calculated for each patient characteristic. Chi-square tests were used to look for differences
in the categorical variables of gender, ethnicity, marital status, education, and type of comorbidities in patients who attended DGMV and patients who received usual care. Independent
t-tests were used to compare means for age, duration of DM, miles from clinic, and number of
co-morbidities. An assumption for use of the chi-square analysis is that the expected count in
each category is greater than 5. If this assumption is violated, the categories of the categorical
variables were collapsed until the assumption was met. A value of p=0.05 was used to determine
significance of the findings.
Aim 7: To explore the impact of dose of DGMVs on biophysical outcomes of care in uninsured
persons with diabetes who receive care in a free clinic after one year.
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To explore the relationship between the dosage of DGMVs and biophysical outcomes of
care in uninsured persons with diabetes who receive care in a free clinic after one year, dose was
collected a continuous variable on a scale from one to six. Correlations were performed with the
outcomes of body weight, BMI, HgA1C, fasting blood glucose, serum creatinine, serum lipids,
urine microalbumin, systolic blood pressure, and diastolic blood pressure at one year for those
patients who attended DGMVs. Before performing a correlation analysis, a scatterplot was
generated to check for violation of the assumptions of linearity. Each continuous variable was
tested for normality. If assumptions of parametric testing were not violated Pearson r was used
for analysis. If assumptions were violated Spearman rho was used for analysis. A value of
p=0.05 was used to determine significance of the findings.
Data Fidelity
Due to the retrospective nature of the study, intervention fidelity is difficult to control.
However, group visits at the clinic were conducted by one diabetes educator, one nurse
practitioner and one medical assistant. The group intervention was held in the same education
room in the clinic and the healthcare portion of the visit was delivered in one of six very similar
exam rooms. The educational content of all of the group visits were derived from one of six
educational sessions developed for a standardized curriculum. The delivery format was
consistent for each DGMV: instruction, questions, answers, goal setting and then individual
patient health examinations.
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CHAPTER 4: RESULTS
The purpose of this study was to examine the relationship between attendance at Diabetes
Group Medical Visits (DGMV) and biophysical outcomes of care in uninsured persons with
diabetes who receive care in a free clinic. This chapter discusses the results of the data analysis
conducted after the retrospective chart review was completed. This chapter will be presented in
the following manner: data collection, data treatment, sample, results, and summary.
Data Collection
The following paragraph describes how the data for this study were obtained. The free
clinic keeps a registry of all persons with diabetes. The registry was reviewed by the researcher
and clinic staff. The charts of all persons with diabetes who received care from May 2007, when
DGMVs were started at the clinic to August 18, 2009, were identified. The clinic underwent a
change to electronic medical records throughout the year 2008. Hence, data were obtained from
previous paper medical records and the current electronic medical records. No patient identifiers
were collected. No information is able to be linked back to the patient. A medical assistant at the
clinic extracted the data from the paper medical record and/or electronic medical record. The
investigator educated the medical assistant about data collection procedures. Additionally, the
medical assistant was provided with a data collection training manual, which was kept in the
clinic as a reference guide. Ten percent of the charts reviewed by the medical assistant were also
reviewed by the investigator. An inter-rater reliability of 95% accuracy between the data
collected by medical assistant and the data collected by the investigator was set and met.
Identified charts were reviewed by the investigator or medical assistant in a private setting in the
clinic. Biophysical outcomes of care were collected from the chart and recorded for two separate
time periods. Biophysical outcomes for patients who did not participate in DGMVs were

41
collected as reported in the chart during or after May 2007 and then again after one year.
Biophysical outcomes of care were collected from the chart of patients who did participate in
DGMVs prior to the initial DGMV and then again in one year.
Sample
This retrospective study was conducted with a convenience sample of patients at a free
clinic in West Virginia. The data were obtained by reviewing the charts of all persons with
diabetes who received care from May 2007 to August 18, 2009. Two independent groups were
studied, those who attended DGMVs and those who received usual care. There were a total of
111 patients who met the inclusion criteria. There were 53 participants who attended DGMVs
and 58 participants who received usual care. This study was approved by the Institutional
Review Board of West Virginia University.
Data Treatment
Data were entered into Microsoft Access and then were transferred into the Statistical
Package of Social Sciences (SPSS), version 18 for analysis of the data. Data were stored on a
USB travel drive which was password protected. The USB travel drive was and will continue to
be kept in a locked office of the investigator when not in use.
Prior to analysis, data were cleaned, looking for outliers or impossible values. Looking
for outliers was accomplished by analyzing frequencies and descriptive statistics and visually
scanning the data for impossible values, missing data and patterns of missing data. Duration of
diabetes had 90.1% missing data. Hence, duration of diabetes was excluded from further
analysis. The variable “depression score” had 27.9 percent (N=22) missing data for the total
sample. The patients who attended group visits had depression scores missing from 11 cases
(9.9%). The patients who received usual care had depression scores missing from 20 cases
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(18%). For the purpose of this study, depression score was analyzed as a characteristic to
describe the groups prior to intervention, not to compare the effectiveness of the intervention.
The missing depression data will be noted as a limitation of the study. Microalbumin had 27%
(N= 30) missing data at time one and 29.7% (N= 33) missing data at time two from the entire
sample. Patients who attended DGMVs had no missing data in microalbumin at time one and 3
cases (2.7%) were missing microalbumin data at time two. Patients who received usual care were
missing microalbumin in 30 cases (27%) at time one and 30 cases (27%) at time two. The
observed power for an independent t-test to compare microalbumin data in those who attended
DGMVs versus usual care at time one and time two (N=78) is 0.616 using a significance level
(p=0.05), and a medium effect size. The observed power for microalbumin data may not be
enough detect a significant difference in microalbumin in those who attended DGMVs versus
usual care at time one and time two. The large amount of missing data for microalbumin for the
patients who received usual care will be listed as a limitation of the study. Patients who received
usual care had 13 cases (11.7 %) of lipid results missing at time two. The observed power for an
independent t-test to compare lipid data in those who attended DGMVs versus usual care at time
one and time two (N =98) is 0.825 using a significance level p=0.05, and a medium effect size.
The observed power for an independent t-test is enough to show a significant difference, if one
exists, in lipid data in those who attended DGMVs versus usual care at time two. No other
variable had greater than 10% missing data.
Statistical Assumptions
The following paragraphs describe the statistical assumptions used for this study. To
compare biophysical outcomes of care in persons with diabetes before attending DGMVs and
again one year after attending DGMVs, paired t-tests were used. Paired t-tests were also used to
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compare means of biophysical outcomes of care in uninsured persons with diabetes who receive
usual care in a free clinic and again after one year. Chi-square tests were used to look for
differences in the categorical variables between patients who attended DGMVs and patients who
received usual care. To examine dose of DGMVs, correlations were performed with biophysical
outcomes at one year for those patients who attended DGMVs.
Normal distribution and random samples are assumptions for both a paired t-test and an
independent t-test. Q-Q plots were used to evaluate normal distribution. If Q-Q plots showed a
normal distribution of the data, paired t-tests or independent t-tests were considered appropriate
to analyze differences in biophysical outcomes. If Q-Q plots showed a non-normal distribution of
the data, either the non-parametric alternative test was used or the Central Limit Theorem was
applied. The non-parametric alternative test for a paired t-test is the Wilcoxon Signed Rank test.
The non-parametric alternative test for an independent t-test is the Mann-Whitney U test. The
Central Limit Theorem states that as the size of a sample of independent observations approaches
infinity, the sampling distribution of the sample mean approaches a normal distribution. Hence,
if n is large enough, typically greater than 30, the Central Limit Theorem can be applied
(http://www.encyclopedia.com/doc/1G2-3045300301.html, 2008). Eta squared is the statistic
used to measure the strength of relationship between two variables for a paired-samples t-test.
Independent t-tests have additional assumptions. To use the independent t-test the data
must be independent of each other. Another assumption of an independent t-test is that the
population variances are equal. In this study, Levene’s test was used to evaluate the assumption
of equal variances. If the Levene’s test p value was larger than .05, equal variances were
assumed. If the Levene’s test p value was less than .05, the results were interpreted using the t
value for the equal variances not assumed test.
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An assumption for use of the chi-square analysis is that the expected count in each
category is greater than 5. If this assumption was violated, the categories of the categorical
variables were collapsed until the assumption was met. If the assumption of an expected count in
each category of greater than 5 could not be met, the data were not analyzed.
Before performing a correlation analysis, scatterplots were generated to check for
violation of the assumptions of linearity. Each continuous variable was tested for normality. If
assumptions of parametric testing were not violated, Pearson r was used for analysis. If
assumptions were violated Spearman rho was used for analysis.
Results
The results will be presented according to the aims of the study. The patient
characteristics will be presented followed by the biophysical outcomes of the sample. Then the
comparison of characteristics and biophysical outcomes between each group will be presented.
Finally, the impact of dose of DGMVs on biophysical outcomes of care will be explored. Each
aim is listed, followed by results and data charts of each result. A value of p=0.05 was used to
determine significance of all findings.
Aim 1: To describe the characteristics of uninsured persons with diabetes who are cared for in a
free clinic.
To describe the characteristics of the study sample, descriptive statistics were used. The
categorical variables gender, ethnicity, marital status, education, and type of co-morbidities were
analyzed using frequencies. The majority of the patients were female, white, married, and had a
high school education or less (See Table 1). Sixty-five percent of the patients were obese and the
majority of the patients had hypertension (84%) and hyperlipidemia (64%). The continuous
variables age, number of co-morbidities, and miles from the subject’s home to the clinic were

45
analyzed using mean and standard deviation. The mean age of the subjects in the study was 48
years. The mean number of co-morbidities was 5 and the mean distance from the patient’s home
to the clinic was 21 miles (See Table 2).

46
Table 1: Sample Characteristics Categorical Variables

Demographic
Variable
Gender

N

Percent

Male

29

26.1

Female

82

73.9

Ethnicity
White

107

95.5

African American

4

3.6

Hispanic

1

0.9

Single

15

13.5

Married

56

50.5

Divorced

24

21.6

Separated

7

6.3

Widowed

9

8.1

Less Than High School

27

24.3

Graduated High School

44

39.6

Some College

20

18.0

Marital Status

Education Level

College Graduate

1

.9

15

13.5

HTN

84

75.7

Kidney Disease

13

11.7

Hyperlipidemia

64

57.7

Heart Disease

18

16.2

Depression

39

35.1

Obesity

73

65.8

Pain

16

14.4

Neuropathy

9

8.1

Frequent Infections

5

4.5

GED

Co-Morbidity
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Table 2: Sample Characteristics Continuous Variables

Demographic

Age in years
Total number of co-morbidities
Distance from clinic in miles

Mean

Range

SD

48
5
21

21-64
0-11
0.7-124

10.8
1.3
20.4

Aim 2: To describe the biophysical outcomes of care in uninsured persons with diabetes who are
cared for in a free clinic.
To describe the biophysical outcomes at time one of the study sample, descriptive
statistics were used. The continuous variables body weight, BMI, fasting blood glucose, HgA1C,
creatinine, lipids, blood pressure, and microalbumin were analyzed using mean and standard
deviation (See Table 3). It is noted that there is a large standard deviation in urine microalbumin.
Because these microalbumin numbers are known to be actual patient results and not aberrant data
entry mistakes, the values were included in the data evaluation. The mean body weight for
subjects in this study was 226.5 pounds and the mean BMI of the subjects was 37.6. The mean
HgA1C in this population was 8%. The mean for urine microalbumin was 52.9 mg. The mean
LDL cholesterol level of this sample was 104.6 mg/dl. The mean HDL cholesterol of this sample
was 40.4mg/dl. The mean triglyceride level of this population was 198.6mg/dl.
Table 3: Biophysical Outcomes of Care

Biophysical
Outcomes

N

Mean

Range

SD

Body Weight (lbs)

111

226.59

121-400

52.71

BMI (kg/mg2)

111

37.60

21.5-58.7

28.48

HgA1C (%)

110

8.09

5-13.6

1.94

Blood Glucose (mg/dl)

111

183.94

51-568

89.55

Creatinine (mmol/l)

111

0.93

.44-4.2

0.45

Microalbumin (mg/mmol)

81

52.95

.20-1120.8

157.96

Systolic (mmHg)

111

129.50

90-190

19.65

Diastolic (mmHg)

111

80.41

59-121

13.15

Total Cholesterol (mg/dl)

108

188.82

88-337

45.80

HDL (mg/dl)

107

40.40

17-83

10.63

LDL (mg/dl)

104

104.65

5-201

40.44

Triglycerides (mg/dl)

103

198.67

36-1156

169.17
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Aim 3: To compare biophysical outcomes of care in persons with diabetes before attending
DGMVs and again one year after attending DGMVs.
To compare biophysical outcomes of care in persons with diabetes before attending
DGMVs and again one year after attending DGMVs, paired t-tests were used. The sample in this
study is not random. This retrospective study was conducted on a convenience sample of patients
at a free clinic in West Virginia. However, paired t-tests are commonly used in retrospective
studies. Q-Q plots were analyzed on the differences between time one and time two for the
following biophysical outcomes: body weight, BMI, HgA1C, fasting blood glucose, serum
creatinine, serum lipids, urine microalbumin, systolic blood pressure, and diastolic blood
pressure. The data did not meet the assumption of normality for the following biophysical
outcomes: body weight, BMI, creatinine, microalbumin, and triglycerides (See Appendix A).
However, since the sample size was large, the results of parametric testing are still valid due to
the Central Limit Theorem. Hence paired-samples t-tests were used to evaluate the impact of
DGMVs on patients’ biophysical outcomes of care.
Means of body weight, BMI, HgA1C, fasting blood glucose, serum creatinine, serum
lipids, urine microalbumin, systolic blood pressure, and diastolic blood pressure before
attendance at DGMVs were compared to means at one year after attending DGMVs. There was a
statistically significant decrease in systolic blood pressure from time one (M=132.32, SD=18.31)
to time two (M=126.83, SD=18.31), t(52)=2.18, (p=0.03). The mean decrease in systolic blood
pressure from time one to time two was 5.49 mm/Hg with a 95% confidence interval ranging
from 0.443 to 10.539, a range of values for the estimated population parameter. The eta squared
statistic (.08) indicated a moderate effect size. No other significant impact on biophysical
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outcomes of care in persons with diabetes before attending DGMVs and again after attending
DGMVs was noted (See Table 4).
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Table 4: Biophysical Outcomes of Care Before and After DGMVs

Biophysical Outcome

N

Mean

Body Weight Time One (lbs)

53

232.11

Body Weight Time Two (lbs)

53

236.38

BMI Time One (kg/mg2)

53

38.21

BMI Time Two (kg/mg2)

53

38.58

HgA1C Time One (%)

53

8.65

HgA1C Time Two (%)

53

8.69

Blood Glucose Time One (mg/dl)

53

194.17

Blood Glucose Time Two (mg/dl)

53

199.92

Creatinine Time One (mg/mmol)

51

0.89

Creatinine Time Two (mg/mmol)

51

0.93

Microalbumin Time One (mg//mmol)
Microalbumin Time Two (mg//mmol)

50
50

59.36
23.60

Systolic Time One (mgHg)

53

132.32

Systolic Time Two (mgHg)

53

126.83

Diastolic Time One (mgHg)

53

81.92

Diastolic Time Two (mgHg)

53

79.85

Total Cholesterol Time One (mg/dl)

52

192.67

Total Cholesterol Time Two (mg/dl)

52

189.63

HDL Time One (mg/dl)

52

40.38

HDL Time Two (mg/dl)

52

41.56

LDL Time One (mg/dl)

48

100.73

LDL Time Two (mg/dl)

48

94.58

Triglycerides Time One (mg/dl)

49

236.31

Triglycerides Time Two (mg/dl)

49

216.63

SD

df

t

p

17.50

52.00

-1.77

0.08

2.78

52.00

-0.095

0.37

1.99

52.00

-0.16

0.87

99.14

52.00

-0.42

0.67

0.27

50.00

-1.05

0.30

165.94

49.00

1.52

0.13

18.31

52.00

2.18

0.03

12.38

52.00

1.22

0.23

48.53

51.00

0.45

0.65

8.93

51.00

-0.95

0.35

44.91

47.00

0.95

0.35

192.56

48.00

0.72

0.48
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Aim 4: To compare biophysical outcomes of care in uninsured persons with diabetes who receive
usual care in a free clinic at baseline and after one year.
To compare means of biophysical outcomes of care in uninsured persons with diabetes
who receive usual care in a free clinic and again after one year paired t-tests were used. Again,
the sample in this retrospective study was not random. However, paired t-tests are commonly
used in retrospective studies. Q-Q plots were analyzed on the differences between time one and
time two for the following biophysical outcomes: body weight, BMI, HgA1C, fasting blood
glucose, serum creatinine, serum lipids, urine microalbumin, systolic blood pressure, and
diastolic blood pressure. For those who receive usual care, the data do not meet the assumption
of normality for the following biophysical outcomes: body weight, HgA1C, BMI, blood glucose,
creatinine, microalbumin, diastolic blood pressure, LDL, and triglycerides (See Appendix B).
However, due to the Central Limit Theorem, parametric testing is still valid for all biophysical
outcomes except microalbumin. The Central Limit Theorem cannot be applied for the
microalbumin outcome, since it contains less than 30 cases. Hence paired-samples t-tests were
used to evaluate the impact of usual care on patients for all biophysical outcomes of care except
microalbumin. Wilcoxon Signed Rank test was used to evaluate the impact of usual care on
microalbumin.
Means of body weight, BMI, HgA1C, fasting blood glucose, serum creatinine, serum
lipids, urine microalbumin, systolic blood pressure, and diastolic blood pressure in patients who
receive usual care at baseline and again after one year were compared. There was no significant
difference between biophysical outcomes of care from time one to time two noted (See Table 5).
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Table 5: Biophysical Outcomes of Care for Usual Care Patients at Baseline and After One Year

Biophysical Outcome

N

Mean

SD

Body Weight Time One (lbs)

58

221.55

57.25

Body Weight Time Two (lbs)

58

221.17

53.27

BMI Time One (kg/mg2)

58

37.08

8.83

BMI Time Two (kg/mg2)

58

36.98

8.10

HgA1C Time One (%)

52

7.52

1.66

HgA1C Time Two (%)

52

7.49

1.55

Blood Glucose Time One (mg/dl)

58

174.59

86.82

Blood Glucose Time Two (mg/dl)

58

175.05

83.95

Creatinine Time One (mg/mmol)

53

0.95

0.61

Creatinine Time Two (mg/mmol)

53

0.97

0.55

Microalbumin Time One (mg//mmol)

19

64.33

140.36

Microalbumin Time Two (mg//mmol)

19

68.87

188.26

Systolic Time One (mgHg)

58

126.93

19.56

Systolic Time Two (mgHg)

58

125.88

13.76

Diastolic Time One (mgHg)

58

79.02

12.71

Diastolic Time Two (mgHg)

58

80.64

11.82

Total Cholesterol Time One (mg/dl)

45

182.02

39.89

Total Cholesterol Time Two (mg/dl)

45

175.87

33.87

HDL Time One (mg/dl)

45

40.89

10.55

HDL Time Two (mg/dl)

45

41.80

10.75

LDL Time One (mg/dl)

42

105.50

32.42

LDL Time Two (mg/dl)

42

97.86

30.75

Triglycerides Time One (mg/dl)

42

171.33

125.86

Triglycerides Time Two (mg/dl)

42

169.57

105.21

df

t

p

57

0.21

.836

57

0.33

.745

51

0.13

.896

57

-0.04

.970

52

-0.60

.548

-.558(z)

.557

57

0.46

.647

57

-0.89

.375

44

1.26

.216

44

-0.94

.351

41

1.49

.145

41

0.09

.929
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Aim 5: To analyze the differences in biophysical outcomes in persons with diabetes who attend
DGMVs versus those who receive usual care in a free clinic at baseline and then again after one
year.
Independent t-tests were used to compare means for body weight, BMI, HgA1C, fasting
blood glucose, serum creatinine, serum lipids, urine microalbumin, systolic blood pressure, and
diastolic blood pressure between the usual care group and the DGMV group at baseline and then
again after one year. Again, the sample in this retrospective study was not random. However,
independent t-tests are commonly used in retrospective studies. Q-Q plots were analyzed to
assess the distribution of each biophysical outcome for patients who attended DGMVs and for
patients who received usual care separately at time one and at time two for the following
biophysical outcomes: body weight, BMI, HgA1C, fasting blood glucose, serum creatinine,
serum lipids, urine microalbumin, systolic blood pressure, and diastolic blood pressure (See
Appendices C & D). For those who attended DGMVs, the data does not meet the assumption of
normality for the following biophysical outcomes at time one and time two: HgA1C, blood
glucose, creatinine, microalbumin, total cholesterol, HDL, LDL, and triglycerides. For those who
received usual care the data does not meet the assumption of normality for the following
biophysical outcomes at time one and time two: HgA1C, blood glucose, creatinine,
microalbumin, systolic blood pressure, diastolic blood pressure, total cholesterol, HDL, LDL,
and triglycerides. However, the results of the parametric test are still valid due to the Central
Limit Therom for the following variables in both groups: HgA1C, blood glucose, creatinine,
systolic blood pressure, diastolic blood pressure, total cholesterol, HDL, LDL, and triglycerides.
The Central Limit Therom cannot be applied to compare the mean of microalbumin between
groups at time one or at time two, because microalbumin contains less than 30 cases in the usual
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care group at both time one and time two. Hence, Mann-Whitney U test was used for the
microalbumin comparisons. The homogeneity of variances assumption was violated for the
biophysical outcomes of HgA1C at time one, LDL at time one, HgA1C at time two, systolic
blood pressure at time two, and triglycerides at time two. Hence, the t value for equal variances
not assumed was used to interpret the results of the comparisons of HgA1C at time one, LDL at
time one, HgA1C at time two, systolic blood pressure at time two, and triglycerides at time two.
To determine if the patients who attended DGMVs had differing biophysical outcomes
than the patients who received usual care prior to the DGMV intervention, means of body
weight, BMI, HgA1C, fasting blood glucose, serum creatinine, serum lipids, systolic blood
pressure, and diastolic blood pressure in patients who attended DGMVs and those who received
usual care at time one were compared. Due to the large amount of missing urine microalbumin
data, the median of urine microalbumin in patients who attended DGMVs and those who
received usual care at time one was used for comparison between the two groups. The patients
who attended DGMVs had a higher HgA1C at baseline (p=0.003). There were no other
significant differences in biophysical outcomes of care noted between the DGMV group and the
usual care group at baseline, indicating that the groups were essentially similar prior to
intervention (See Table 6).
To examine differences in biophysical outcomes one year after attending DGMVs or
receiving usual care, means of body weight, BMI, HgA1C, fasting blood glucose, serum
creatinine, serum lipids, systolic blood pressure, and diastolic blood pressure at time two were
compared. Due to the large amount of missing urine microalbumin data, the medians of urine
microalbumin in patients who attended DGMVs and those who received usual care at time two
were compared. The patients who attended DGMVs continued to have a higher HgA1C after one
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year (p=0.001). There were no other significant differences in biophysical outcomes of care
noted between the DGMV group and the usual care group at one year (See Table 7).
Although not statistically significant, the biophysical outcomes did change in the sample
(See Table 8). Body weight increased in the DGMV group and BMI increased in both groups
from time one to time two. Blood glucose increased in both groups from time one to time two.
Creatinine increased in the DGMV group from time one to time two. Microalbumin decreased in
both groups from time one to time two. Systolic blood pressure decreased in both groups.
Diastolic blood pressure decreased in the DGMV group and increased in the usual care group
from time one to time two. Total cholesterol decreased in both groups and HDL increased in
both groups from time one to time two. LDL decreased in both groups from time one to time
two. Triglycerides decreased in the DGMV group and increased in the usual care group from
time one to time two. The only difference between the two groups at baseline was that the
patients who attended DGMVs had a statistically higer HgA1C. The patients who attended
DGMVs continued to have a statistically significant higher HgA1C after one year. While the
groups were equivalent except for a higher HgA1C in the group of patients who attended
DGMVs, there were no other significant differences in biophysical outcomes of care noted at
baseline or after one year.
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Table 6: Differences in Biophysical Outcomes in Those Who Attend DGMVs versus Usual Care at Baseline

Biophysical Outcome

Mean

SD

df

t

p

Group Visits
Usual care

232.11
221.55

47.17
57.25

109

1.06

.294

Group Visits
Usual care

38.21
37.08

40.09
8.83

109

1.23

.222

Group Visits
Usual care

8.65
7.57

2.09
1.64

108

3.02

.003

Group Visits
Usual care

194.17
174.59

92.18
86.82

109

1.15

.252

Group Visits
Usual care

0.89
0.97

0.19
0.60

109

-0.87

.384

Group Visits
Usual care

3.2(Md)
6.8(Md)

-1.053(z)

.292

Systolic Blood Pressure (mgHg)
Group Visits
Usual care

132.32
126.93

19.54
19.56

109

1.45

.150

Diastolic Blood Pressure (mgHg)
Group Visits
Usual care

81.92
79.02

13.58
12.71

109

1.17

.246

Group Visits
Usual care

192.72
185.07

50.05
41.41

106

0.87

.388

Group Visits
Usual care

40.38
40.43

10.65
10.71

105

-0.02

.981

Group Visits
Usual care

100.42
108.88

45.22
34.96

102

-1.07

.288

Group Visits
Usual care

227.83
168.94

202.32
121.83

101

1.79

.077

Body Weight (lbs)

BMI (kg/mg2)

HgA1C (%)

Blood Glucose(mg/dl)

Creatinine (mg/mmol)

Microalbumin (mg/mmol)

Total Cholesterol (mg/dl)

HDL (mg/dl)

LDL (mg/dl)

Triglycerides (mg/dl)
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Table 7: Differences in Biophysical Outcomes in Those Who Attend DGMVs versus Usual Care at One Year

Biophysical Outcome

Mean

SD

df

t

p

Body Weight (lbs)
Group Visits
Usual care

236.38
221.17

52.69
53.27

109

1.51

.134

Group Visits
Usual care

38.58
36.98

8.48
8.10

109

1.01

.313

Group Visits
Usual care

8.69
7.48

2.23
1.54

104

3.27

.001

Blood Glucose(mg/dl)
Group Visits
Usual care

199.92
175.05

102.76
83.95

109

1.40

.164

Creatinine (mg/mmol)
Group Visits
Usual care

0.93
0.97

0.28
0.55

102

-0.45

.653

Microalbumin (mg/mmol)
Group Visits
Usual care

2.75(Md)
6.0(Md)

7

-1.683

.092

Systolic Blood Pressure
(mgHg)
Group Visits
Usual care

126.83
125.88

19.21
13.76

109

0.30

.763

Diastolic Blood Pressure
(mgHg)
Group Visits
Usual care

79.85
80.64

11.74
11.82

109

-0.35

.725

Total Cholesterol (mg/dl)
Group Visits
Usual care

189.63
176.63

55.55
33.89

96

1.38

.172

Group Visits
Usual care

41.56
41.87

11.84
10.64

96

-0.14

.892

Group Visits
Usual care

95.41
95.84

38.16
33.15

90

-0.06

.955

Triglycerides (mg/dl)
Group Visits
Usual care

216.30
172.02

151.48
105.19

91

1.61

.111

BMI (kg/mg2)

HgA1C (%)

HDL (mg/dl)

LDL (mg/dl)
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Table 8: Changes in Biophysical Outcomes in Those Who Attend DGMVs versus Usual Care at Time Two

Biophysical
Body
Weight (lbs)
Outcome
BMI (kg/mg2)
HgA1C (%)
Blood Glucose(mg/dl)
Creatinine (mg/mmol)
Microalbumin (mg/mmol)
Systolic Blood Pressure
Diastolic(mgHg)
Blood Pressure
(mgHg)
Total Cholesterol (mg/dl)
HDL (mg/dl)
LDL (mg/dl)
Triglycerides (mg/dl)
▼= decrease

▲=increase

DGMVs
▲
▲
▬
▲
▲
▼
▼
▼
▼
▲
▲
▼

▬ = no change

Usual Care
▬
▲
▬
▲
▬
▼
▼
▲
▲
▲
▲
▲
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Aim 6: To analyze the differences in characteristics of uninsured persons with diabetes who are
attendees of DGMVs verses those who receive usual care.
Chi-square tests were used to look for differences in the categorical variables of gender,
ethnicity, marital status, education, and type of co-morbidities between patients who attended
DGMVs and patients who received usual care. An assumption for use of the chi-square analysis
is that the expected count in each category is greater than 5. Education level and ethnicity
violated the assumptions by having an expected count of less than 5 observations in several
categories. Education level had only one participant that graduated from college and no
participants graduated or attended graduate school. Hence, the categories were collapsed. The
participant who graduated from college was included in the “some college” category and the
“master’s degree” and “doctoral degree” categories were removed. There were only five
participants who reported being anything other than white. Hence, the categories were collapsed
into white and non-white. The expected count was still less than 5 observations in ethnicity.
Therefore, the characteristic of race/ethnicity was not analyzed. Marital status had an expected
count of less than 5 observations in several categories. The marital status category was
compressed into the categories married and not married. Any participant who was listed as
single, divorced, separated, widowed was placed in the non-married category. Participants who
were listed as married were placed in the married category.
Independent t-tests were used to compare means for the continuous characteristics of age,
miles from clinic, and number of co-morbidities between patients who attended DGMVs and
patients who received usual care. Again, the sample in this retrospective study was not random.
However, independent t-tests are commonly used in retrospective studies. Q-Q plots were used
to assess distribution of age, miles from clinic, and number of co-morbidities for patients who
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attended DGMVs and for patients who received usual care separately (See Appendices E & F).
The data do not meet the assumption of normality for those who attended DGMVs or patients
who received usual care. However, the results of the parametric test are still valid due to the
Central Limit Theorem.
The Chi-square test for independence indicated the patients who participated in DGMVs
differed from the usual care group prior to the intervention by reporting significantly higher rates
of the presence of depression, obesity and pain (See table 9). Independent t-tests showed no
difference between the means for the continuous characteristics of age, miles from clinic, and
number of co-morbidities between patients who attended DGMVs and patients who received
usual care (See table 10). There were no other significant differences in characteristics at the
beginning of the study between those who attended DGMVs and those who received usual care.
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Table 9: Differences in Characteristics of DGMVs versus Usual Care Using X2

Characteristic

Gender
DGMV
Male
Female
Usual Care
Male
Female
Marital Status
DGMV
Not Married
Married
Usual Care
Not Married
Married
Education
DGMV
Less than High School
Graduated High School
Some College
GED
Usual Care
Less than High School
Graduated High School
Some College
GED
HTN
DGMV
Has HTN
No HTN
Usual Care
Has HTN
No HTN
Kidney Disease
DGMV
Has Kidney Disease
No Kidney Disease
Usual Care
Has Kidney Disease
No Kidney Disease
Hyperlipidemia
DGMV
Has Hyperlipidemia
No Hyperlipidemia
Usual Care
Has Hyperlipidemia
No Hyperlipidemia
Heart Disease
DGMV
Has Heart Disease
No Heart Disease
Usual Care
Has Heart Disease
No Heart Disease

N

%

X2

Sig

14
39

26.4
73.6

0.004

0.947

15
43

25.9
74.1

29
24

54.7
45.3

1.083

0.298

26
32

44.8
55.2

13
22
10
8

24.5
41.5
18.9
15.1

0.122

0.989

15
23
12
8

25.9
39.7
20.7
13.8

40
13

75.5
24.5

0.002

0.962

44
14

75.9
24.1

8
45

15.1
84.9

1.122

0.289

5
53

8.6
91.4

28
25

52.8
47.2

0.968

0.325

36
22

62.1
37.9

9
44

17
83

0.044

0.834

9
49

15.5
84.5
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Depression
DGMV
Has Depression
No Depression
Usual Care
Has Depression
No Depression
Obesity
DGMV
Has Obesity
No Obesity
Usual Care
Has Obesity
No Obesity
Pain
DGMV
Has Pain
No Pain
Usual Care
Has Pain
No Pain
Neuropathy
DGMV
Has Neuropathy
No Neuropathy
Usual Care
Has Neuropathy
No Neuropathy
Frequent Infections
DGMV
Has Frequent Infections
No Frequent Infections
Usual Care
Has Frequent Infections
No Frequent Infections

24
29

45.3
54.7

15
43

25.9
74.1

41
12

77.4
22.6

32
26

55.2
44.8

12
41

22.6
77.4

4
54

6.9
93.1

6
47

11.3
88.7

3
55

5.2
94.8

3
50

5.7
94.3

2
56

3.4
96.6

4.583

0.032

6.055

0.014

5.565

0.018

1.405

0.236

0.315

0.575
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Table 10: Differences in Characteristics of DGMVs verses Usual Care Using Independent t-tests

Characteristic

Mean

SD

t

p

DGMV

47

10.82

1.13

0.261

Usual Care

49

10.84

DGMV

4.7

2.16

-1.31

0.193

Usual Care

4.2

2.11

DGMV

20.7

19.72

0.25

0.803

Usual Care

21.7

21.08

Age

Number of Co-Morbidities

Distance from Clinic

Aim 7: To explore the impact of dose of DGMVs on biophysical outcomes of care in uninsured
persons with diabetes who receive care in a free clinic after one year.
To explore the relationship between the dosage of DGMVs and biophysical outcomes of
care in uninsured persons with diabetes who receive care in a free clinic after one year, dose was
collected as a continuous variable on a scale from one to six. Correlations were performed with
the outcomes of body weight, BMI, HgA1C, fasting blood glucose, serum creatinine, serum
lipids, urine microalbumin, systolic blood pressure, and diastolic blood pressure at one year for
those patients who attended DGMVs. Before performing a correlation analysis, scatterplots were
generated to check for violation of the assumptions of linearity. The scatterplots were visually
scanned for outliers. When correlations were performed, no significant correlations were found
between number of DGMVs attended and biophysical outcomes of care (See table 11). However,
after analyzing frequencies, it is noted that only 18 individuals attended 3 or more DGMVs.
Seventeen participants attended one visit and 18 participants attended two visits. The data were
then collapsed into participants who attended 3 or more group visits and those who attended less
than three visits. Because HgA1C is so commonly used to determine an improvement in glucose
levels, HgA1C was also collapsed into goal met or goal not met. The American Diabetes

64
Association sets the goal for HgA1C at less than 7%. The continuous biophysical outcome of
HgA1C was dichotomized using 7% as a threshold to create a new variable, those who were
above 7% and 7% and below. A Chi-square test was used to analyze the differences between
participants who attended 3 or more group visits and those who attended less than three visits
and HgA1C goal met or not met. There were no significant differences between the HgA1C met
or not met outcome of patients who attended three or more DGMVs and those who attended less
than three DGMVs (See Table 12).
Table 11: Correlation between Dose of DGMVs and Biophysical Outcomes

Pearson
Correlation
Sig.
N

Pearson
Correlation
Sig.
N

Body
Weight
Time
Two

BMI
Time
Two

HgA1C
Time Two

Blood
Glucose
Time
Two

Creatinine Microalbumin
Time Two
Time Two

.162

.101

-.041

-.014

-.017

-.161

.248

.473

.769

.918

.906

.263

53

53

53

53

51

50

Systolic
Time
Two

Diastolic
Time
Two

Total
Cholesterol
Time Two

HDL
Time
Two

LDL Time
Two

Triglycerides
Time Two

.150

-.086

-.156

-.158

.108

-.133

.284

.540

.269

.263

.459

.357

53

53

52

52

49

50
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Table 12: X2 for Dose of DGMVs & HgA1C Goal

2 or less DGMVs
HgA1C at goal
HgA1C above goal
3 or more DGMVs
HgA1C at goal
HgA1C above goal

N

%

X2

Sig

10
25

28.6
71.4

0.518

0.323

7
11

38.9
61.1

Summary
This retrospective study was conducted with a convenience sample of patients at a free
clinic in West Virginia. The majority of uninsured persons with diabetes who are cared for in this
free clinic are female, white, married, with a high school education or less. There was a
statistically significant decrease in systolic blood pressure from time one to time two in patients
who attended DGMVs. No other significant impact on biophysical outcomes of care in persons
with diabetes after attending DGMVs was noted. There was no significant impact on biophysical
outcomes of care in patients who received usual care from time one to time two noted. The
patients who attended DGMVs had a higher HgA1C at baseline than those who received usual
care. The patients who attended DGMVs continued to have a higher HgA1C after one year than
those patients who received usual care. Dose of DGMVs did not impact biophysical outcomes of
care in uninsured persons with diabetes who received care in a free clinic.
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CHAPTER 5: SUMMARY, DISCUSSION, AND IMPLICATIONS
The purpose of this study was to examine the relationship between attendance at Diabetes
Group Medical Visits (DGMV) and biophysical outcomes of care in uninsured persons with
diabetes who receive care in a free clinic. The aims of the study were to describe the
characteristics of uninsured persons with diabetes cared for in a free clinic, describe the
biophysical outcomes of care, explore the differences in biophysical outcomes of care before and
after attending DGMVs versus receiving usual care, and explore the impact of dose of DGMVs
on biophysical outcomes of care. The subjects included in this study were in poor health.
DGMVs had very little impact on biophysical outcomes of care in this study. This chapter
interprets the results of the data analysis guided by the major concepts of the Quality Health
Outcomes Model (QHOM), presents a discussion of the findings as compared to current
literature, presents the limitations of the study, and suggests implications for future practice and
research.
Theoretical Framework
The theoretical framework used to guide this study was the QHOM. The four major
concepts included in this model are: system, interventions, patients, and outcomes. The QHOM
posits that system characteristics are the mediators of patient characteristics and interventions in
producing patient outcomes (Mitchell, et al., 1998). The QHOM proposes that outcome measures
should be the result of care interventions that integrate functional, social, psychological,
physical, and physiologic aspects of people’s experience in health and illness (Mitchell et al.,
1998).The QHOM further postulates that interventions affect and are affected by both the system
and patient characteristics in producing desired outcomes (Mitchell, et al., 1997). Additionally,
according to the QHOM, patient characteristics can affect outcomes of care.
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The design of this study was guided by major concepts of the QHOM. The system in this
study was a free clinic in North Central West Virginia, the intervention was DGMVs, the
patients were low income uninsured adults, and the outcomes were biophysical measures. The
environment of the clinic and the pre-existing qualifications necessary to become a patient at the
free clinic affected the characteristics of the sample. Consequently, patient characteristics such as
suboptimal physical condition, multiple co-morbid conditions, less education, younger age,
longer driving distances to obtain care, Appalachian culture and lack of health care insurance
influenced participation in the intervention and outcomes. Despite the intervention, the outcomes
of care were essentially unchanged in subjects in this study, likely due to complex characteristics
of persons who attended the free clinic. While the outcomes of the patients in this study were not
positively impacted by the intervention, the framework of the QHOM was supported. The
following paragraphs will show the relationships between patient characteristics, intervention
and outcomes.
Findings
Patient Characteristics
The characteristics of uninsured adult patients who are cared for in a free clinic are not
well documented in the literature. Hence, the first aim of this study was to describe the
characteristics of uninsured persons with diabetes who are cared for in a free clinic. This study
described age, gender, ethnicity, marital status, duration of DM, education, miles from clinic, comorbidities, and depression in this population. Participants had a mean of 5 co-morbid conditions
other than diabetes. The majority of the patients were female, white, had a high-school education
or less, and were age 50 or younger. The subjects being cared for in this free clinic drove long
distances to receive care.
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Number of co-morbid conditions has been documented to affect outcomes of care.
Patients with a greater overall number of co-morbidities place lower priority on diabetes and
have worse diabetes self-management ability scores (Glasgow, et al., 1996). Self-management of
diabetes, such as checking glucose levels, taking medications, and adhering to dietary and
activity recommendations is necessary to maintain optimal biophysical outcomes of care
(American Diabetes Association, 2010).
Gender has been documented to affect outcomes such as rates of obesity, amount of
physical activity, and adherence. Females have a greater prevalence of obesity compared to
males (Ferraro et al., 1992). Obesity causes insulin resistance which contributes to decreased
effectiveness in lowering blood glucose. The resulting increase in blood glucose may raise levels
outside the normal range and cause adverse health effects (McPhee, 2011). Men with diabetes
have been found to be more physically active than women with diabetes (Carpenter, 1998) which
may significantly lower cardiovascular risks and overall mortality (Church et al., 2004). Further,
women have been found to consume more calories, make poor food choices and have lower
levels of adherence than men (Whitlock, et al., 1997).
Nearly all participants in this study were white. In order to receive care at this free clinic,
subjects must have resided in West Virginia. West Virginia is in the only state that is entirely in
Appalachia (AppalachianRegionalCommission, Retrieved 2011-06-04). Although this study did
not collect data on culture, all of the participants of this study live in West Virginia. According to
the 2000 United States Census, 74.2 percent of people residing in West Virginia are native to
West Virginia (U.S.CensusBureau, 2000). Hence, it is the assumption of the researcher that the
subjects of this study are members of Appalachian culture, and therefore subscribe to some of the
social norms of the culture. These norms and beliefs affect the patients’ desire to interact with a
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care delivery system (Holzemer, 1994). People from Appalachian culture possess core values
such as individualism, self-reliance, and fatalism (Smith & Tessaro, 2005). These core values
may affect a patient’s willingness to share personal information with outsiders. An outsider can
be any person that is not familiar to the patient such as other patients and health care providers
participating in group visits. In order for DGMVs to affect outcomes of care, each patient must
share similar experiences and be willing to participate in a group (Barud, et al., 2006).
Education level also appears to have an effect on participation in medical decision
making and thus may impact outcomes of care (DeWalt, et al., 2007). Over one third of subjects
in this study did not graduate high school. Educational level has been shown to be significant in
disease control of persons with diabetes. On the National Health and Nutrition Examination
Survey (NHANES) from 1999 to 2006, those persons with diabetes who had a high school
education or greater had consistently shown improved outcomes such as decreased HgA1C,
decreased blood pressure and decreased total cholesterol levels than those who were less
educated (McWilliams, et al., 2009).
The age of all subjects in this study is less than 65 and the majority of the subjects were
age 50 and younger. Younger adult patients, less than 60 years old, are significantly less likely to
attend education programs and multiple healthcare visits than older adult patients (Abdulwadud
et al., 1997). Additionally, the largest reductions in HgA1C have been documented in patients
who attend more healthcare visits (Brown et al., 2005). Consequently, lack of attendance to
multiple healthcare visits and education programs by younger populations may contribute to
decreased effectiveness of interventions.
Longer driving distances from home to the site of primary care have been associated with
poorer outcomes in rural subjects (Strauss, et al., 2006). The majority of subjects in this study
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live greater than twenty miles from the clinic making both traveling time to clinic and
transportation difficult. Living far away from primary health care centers, particularly in West
Virginia presents multiple barriers to care. These barriers include inability to quickly access care
due to distance, lack of an interstate transportation system, lack of public transportation systems,
and cost of transportation (Arcury, Preisser, Gesler, & Powers, 2005). These barriers affect a
person's ability and willingness to obtain needed care (Arcury et al., 2005).
Biophysical Outcomes Prior to Intervention
The biophysical outcomes of patients who are cared for in a free clinic are not well
documented in the literature. The second aim of this study was to describe the biophysical
outcomes of care in uninsured persons with diabetes who are cared for in a free clinic. The
outcomes examined in this study were body weight, BMI, fasting blood glucose, HgA1C,
creatinine, lipids, blood pressure, and microalbumin. An outcome is said to be a component of a
patient’s clinical and functional status after an intervention has been applied (Barr, et al., 2001).
The biophysical outcomes of care of uninsured persons with diabetes who are cared for in this
free clinic indicate suboptimal control of multiple co-morbid conditions.
The mean BMI was in the severe obesity category for this sample of patients (Sturm,
2007). Only 5% of this sample of patients had a BMI indicating normal body weight. The
remaining 95% of this sample of patients were in the overweight to morbid obesity categories.
According to the Standards of Medical Care released by the American Diabetes Association,
weight loss has been shown to reduce insulin resistance. Insulin resistance leads to higher levels
of blood glucose. The resulting increase in blood glucose can cause adverse health effects
(McPhee, 2011).
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The mean HgA1C in this population was 8.09 percent. Having a HgA1C above 8 percent
means that the average daily blood glucose of this sample of persons with diabetes is above
200mg/dl indicating significant chronic hyperglycemia (AmericanDiabetesAssociation, 2010).
Current recommendations are set at achieving and maintaining a HgA1C of less than 7% for
most patients (Nathan et al., 2009). More than 60% of the patients in this sample have HgA1C
levels higher than recommended treatment goals. The American Diabetes Association suggests
lowering HgA1C to below or around 7% in order to reduce microvascular and neuropathic
complications of diabetes which contribute to blindness, chronic kidney disease, and lower limb
amputations.
While creatinine levels were normal in this sample, urine microalbumin was elevated.
Maintaining normal creatinine levels and urine microalbumin reduce the risk of macrovascular
disease. Persistent elevated urine microalbumin has been shown to be the earliest indication of
diabetic nephropathy in diabetes patients (Garg JP, 2002). The level of microalbumin in this
sample was in the range that indicates diabetic nephropathy. Microalbuminuria and nephropathy
are also a well-established markers of increased coronary vascular disease risk (Garg JP, 2002).
The lipid levels of this sample indicated dyslipidemia. According to the American
Diabetes Association, patients with diabetes have an increased prevalence of lipid abnormalities,
which contributes to their high risk of coronary vascular disease. According to the American
Diabetes Association, low levels of HDL cholesterol associated with elevated LDL and
triglyceride levels, which are seen in this population, are the most prevalent pattern of
dyslipidemia in persons with diabetes. Elevating HDL and lowering LDL and triglyceride levels
are crucial to preventing stroke, myocardial infarction, and other vascular complications
(AmericanDiabetesAssociation, 2010).
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Usual Care Group Outcomes
The forth aim of this study was to compare biophysical outcomes of care in patients who
received usual care at baseline and again after one year. There were no significant differences
between biophysical outcomes of care from time one to time two noted in those who received
usual care. The subjects in this group were severely obese, with elevated HgA1C levels,
nephropathy, and dyslipidemia at baseline and continued to be in sub-optimal physical condition
after one year of usual care.
The majority of patients who received usual care in this free clinic had five or more
visits to the clinic in the course of one year. Persons with diabetes who are treated with insulin
should be seen by their healthcare provider at least every three to four months. Those who are
treated with oral medications or who are managing diabetes through diet should be seen at least
every four to six months (AmericanDiabetesAssociation, 2010). Hence, the subjects in this study
who received usual care attended the clinic and received care at least as often as recommended
by the ADA, if not more frequently. However, attending the clinic and receiving usual care did
not affect outcomes of care in this sample of patients. These findings are similar to previous
findings related to usual diabetes care. Despite advancing treatment options and providing
ongoing diabetes care, biophysical outcomes of diabetes care continue to be less than optimal
(SERVICES, et al., 2008).
DGMV Intervention Group Outcomes
There were differences in the biophysical outcomes found in the sample of patients who
attended DGMVs. Previous to the intervention, HgA1C was elevated in the patients who
attended DGMVs and remained elevated after one year. Maintaining high HgA1C levels
increases the risk of long-term complications of diabetes. Mean systolic blood pressure
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decreased to acceptable levels based on clinical guidelines (AmericanDiabetesAssociation, 2002)
in the patients who attended DGMVs after one year. People with both diabetes and hypertension
have approximately twice the risk of cardiovascular disease than patients who have hypertension
alone. Hence, reducing and maintaining blood pressure can decrease cardiovascular risk.
However, there were no other significant differences in biophysical outcomes of care in the
patients who participated in DGMVs after one year of care.
The biophysical outcomes reported in other literature related to DGMVs showed that
participants started nearer to treatment goals prior to intervention than the sample of patients in
this study (Chiu, et al., 2009; Clancy, Brown, et al., 2003; Clancy, Yeager, et al., 2007; CulhanePera, et al., 2005; Guzek, et al., 2009; Trento, et al., 2002; Trento, et al., 2001; Wagner, et al.,
2001). Most studies reviewed related to DGMVs reported HgA1C levels from 6.9-7.6 %
(Keyserling et al., 2002; Wagner, 1998; Wagner, et al., 2001). Nearly 70% of the sample of
patients who attended DGMVs had HgA1C levels above treatment goals at time one.
Additionally, greater than 62% of the sample of patients who attended DGMVs had HgA1C
levels above what has been previously seen in the literature. However, while HgA1c values are
reported in most of the DGMV literature, other biophysical outcomes of care are inconsistently
studied, making comparisons difficult. Suboptimal biophysical outcomes and complex patient
characteristics of this sample make implementing interventions complex and perhaps less
effective than in other populations.
Another aim of this study was to explore the impact of dose of DGMVs on biophysical
outcomes of care. Participants were able to attend up to six DGMVs in which they would be
provided education about blood glucose monitoring, medication, nutrition, exercise, foot care,
heart disease, complications including sick day care, and behavior changes. In addition to their
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regular clinic visits, the patients can attend the clinic monthly until they have received all of the
education offered by DGMVs. There was no significant relationship found between number of
DGMVs attended and biophysical outcomes of care in this study. However, it is important to
note that the majority of patients attended two or less DGMVs in one year. Previous studies
reviewed related to DGMVs suggest that improved interventions are seen in those patients who
attend DGMVs more frequently (Beck, et al., 1997; Trento, et al., 2002; Trento, et al., 2001).
Other studies that reported improvement in measured biophysical outcomes related to
participation in DGMVs measured outcomes after at least 2 years of care (Clancy, Huang, et al.,
2007; Trento, et al., 2002). Hence, the lack of improvement in biophysical outcomes of care in
this sample of patients who attended DGMVs may be due to low attendance rates or less time
between intervention and outcome measurement than in previous studies.
Comparison of Usual Care and DGMV Intervention group outcomes
There were differences in patient characteristics in the sample of patients who attended
DGMVs versus those who received usual care. Similar to the usual care group, the DGMV group
had elevated HgA1C levels, nephropathy, and dyslipidemia. However, patients who participated
in DGMVs had higher depression scores, were more obese and reported to have pain more
frequently than patients who received usual care in this study. Patients with depression are more
likely to experience complications of diabetes, have worse glycemic control, and be less adherent
to self-care behaviors than patients who are not depressed (J. O. Prochaska, 2008). Pain has been
found to limit a person’s ability to perform self-management behaviors (Krein, Heisler, Piette,
Makki, & Kerr, 2005). Obesity increases the incidence of insulin resistance, hypertension,
dyslipidemia, and cardiovascular disease (DeFronzo & Ferrannini, 1991). These group

75
differences could have contributed to diminished response to the intervention when compared to
the usual care group.
While this study did not measure improvements to the process of providing healthcare, an
unexpected healthcare system improvement was found. Traditionally, DGMVs have been
delivered by physicians with the assistance of nurses or diabetes educators in fee for service
healthcare organizations. The intervention studied here employed a Nurse Practitioner and a
PharmD who is a Diabetes Educator. This innovative collaborative approach to deliver care
resulted in urine microalbumin being measured and charted more frequently in the subjects who
attended DGMVs. Having the entire picture of the patients health status by reviewing previously
charted biophysical outcomes of care allows the healthcare team to make more informed
decisions regarding the future care of the patient (Honoré, 2010). Thus, this finding suggests that
a collaborative approach may improve the process of providing care even if biophysical
outcomes of care remained essentially unchanged for both participants of DGMVs and usual care
patients.
Implications for Practice
Clinical outcomes associated with group visits have been documented to include
decreased or stable HgA1C, decreased cardiovascular risk, decreased or stable BMI, decreased
LDL, increased HDL, decreased or stable blood pressure and slowed progression of retinopathy
(Clancy, Cope, et al., 2003). However, DGMVs were not effective in improving biophysical
outcomes of care in the population of persons with diabetes cared for in this free clinic. In the
future, assessment of humanistic outcomes such as quality of life improvement, improved patient
care delivery, and improved patient satisfaction may be useful in assessing the effectiveness of
DGMVs in this population. The implementation of DGMVs may be a viable option for
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improving biophysical outcomes of care in some patient populations. Prior to implementation of
DGMVs as an intervention, assessment of both the characteristics of the patients to be cared for
and the system in which DGMVs will take place is advised.
The patient characteristics found in previous studies to contribute to the success of
DGMVs as an intervention include ethnic minority groups, female gender, older age, and some
type of health care insurance. The results of the current study suggest that other patient
characteristics such as pre-existing multiple co-morbid conditions other than diabetes, education
level, depression, pain, and distance to the clinic can negatively affect biophysical outcomes of
care and the impact of DGMVs. Future interventions for this population should be tailored to
treat people who have diabetes and multiple co-morbid conditions, depression, pain, and live
long distances from the clinic The addition of services from other disciplines such as social
work or behavioral health for this population may contribute to improved outcomes.
In addition to tailoring interventions based on patient characteristics, an assessment of the
healthcare delivery system is necessary. This study tested an intervention that was originally
designed to operate within a traditional healthcare delivery system. The system of interest, the
free clinic, cannot operate in the same ways as fee for service practices. Future interventions that
investigate changes in the healthcare delivery system are warranted. In addition to the Nurse
Practitioner and Pharm D, other healthcare professionals are needed to address the severe
obesity, poor physical condition, and macrovascular complications seen in this population.
Instead of an additional health care visit that is meant to supplement individual healthcare,
clustered care visits where a multidisciplinary health care team work together to assess,
diagnose, treat and educate are needed (Funnell, 2004). Another idea might be the use of
innovative technologies or the use of home care services to provide distance care and
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individualized education for this population. Based on these study results, implementation of
DGMVs is only suggested if the clinic is easily accessible and can provide care from multiple
healthcare team members. New interventions will require not only a change in practice for
primary health care providers but in the healthcare delivery system.
Future Research
Future research with this population should focus on the unique needs of persons with
diabetes who receive care in free clinics. It is clear that this population is different than those
previously studied using DGMVs as an intervention. In 2008, the National Center for Health
Statistics reported that 46 million individuals under the age of 65 were uninsured, which
translates to 16.8 percent of the population of adults under the age of 65 without insurance
(CDC, 2006). Differing characteristics of uninsured patients such as obesity, multiple co-morbid
conditions, less education, younger age, longer driving distances, Appalachian culture, and low
incomes provide target areas for future tailored intervention research.
Future research should include multi-site randomized clinical trials with consistent
measures of biophysical outcomes related to DGMVs. Randomization to treatment group would
correct self-selection to the intervention and non-equal groups as seen in this study. Additionally,
future research should control for the dose of the intervention and separate the researcher role
from clinician role. While HgA1c values are reported outcome measures in most of the DGMV
literature, other biophysical outcomes of care are inconsistently reported. Prospective studies are
needed to evaluate the biophysical outcomes of care in persons with diabetes when innovative
care models are used. Such biophysical outcomes include body weight, BMI, HgA1C, fasting
blood glucose, serum creatinine, serum lipids, urine microalbumin, and blood pressure.
Measuring and reporting consistent biophysical outcomes as suggested by the American
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Diabetes Association will assist researchers and clinicians in comparing the impact of DGMVs
on outcomes.
Many factors have been implicated in affecting outcomes for persons with diabetes. This
study only investigated biophysical outcomes of care. This study did not investigate other
outcome measures such as improving quality of life or improvements in the process of providing
care. Previous research has documented that those persons with diabetes who were willing
participate in DGMVs experienced an increase in satisfaction with care, interaction with
providers, diabetes knowledge, education, quality of life and preventive procedures and
screenings (Trento, et al., 2001; Wagner, et al., 2001). Additionally, positive outcomes have been
achieved in other populations with an increase in provider trust and a decrease or more effective
use of provider time (Clancy, Cope, et al., 2003). Longitudinal studies are needed to investigate
how improved quality of life, provider relationships, and knowledge of disease processes could
impact long-term negative consequences of diabetes.
Limitations
The study design was based on a convince sample of persons with diabetes who attended
at a free clinic in West Virginia from May 2007 to August 18, 2009. The generalizability of
results is limited to the specific population of the study, given that the sample consisted of
predominantly white, middle-aged females. Furthermore, due to the retrospective nature of the
study, only the variables present in the chart could be collected.
This study did not take in to consideration the barriers to attending DGMVs for this
population. Out of the possible 326 patients who received care at the clinic during the study
timeframe, only 111 patients could be included in the study. The participants who were excluded
did not have two visits within one year during the study timeframe and hence, one year
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comparisons could not be made. Attendance at clinic appointments was unpredictable, with the
cancellation rate being high for many patients. Many factors have been implicated in affecting
outcomes, such as readiness for change, lack of transportation, financial burden, culture, age,
gender, co-morbid conditions, and knowledge. Future prospective studies could personalize
interventions towards individual patients and their families, cluster care, assess for readiness to
change, and address financial burden. Such studies would address the barriers to attending
DGMVs found in this population.
Another limitation is the ability of the study to examine confounding factors that may
influence patient characteristics and biophysical outcomes of care. Out of the possible 326
patients who received care at the clinic during the study timeframe, only 111 patients could be
included in the study. The participants who were excluded did not have two visits within one
year during the study timeframe and hence, one year comparisons could not be made.
Attendance at clinic appointments is unpredictable, with the cancellation rate being high for
many patients. Many factors have been implicated in affecting outcomes, such as low attendance
rates, lack of social support, financial burden, decreased access to care, culture, and knowledge.
This study only collected demographic and outcome variables available in the chart.
One more limitation of the study is missing data. The patients who received usual care
had depression scores missing from 20 cases (18%). Depression score was analyzed as a
characteristic to describe the groups prior to intervention, not to compare the effectiveness of the
intervention. However, because patients with depression are more likely to experience
complications of diabetes, have worse glycemic control, and be less adherent to self-care
behaviors than patients who are not depressed, examining differences in depression data before
and after intervention could be meaningful. Microalbumin had 27% (N= 30) missing data at
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time one and 29.7% (N= 33) missing data at time two from the entire sample. Patients who
attended DGMVs had no missing data in microalbumin at time one and 3 cases (2.7%) were
missing microalbumin data at time two. Patients who received usual care were missing
microalbumin in 30 cases (27%) at time one and 30 cases (27%) at time two. The observed
power for microalbumin data may not be enough detect a significant difference in microalbumin
in those who attended DGMVs versus usual care at time one and time two. The large amount of
missing microalbumin data for the patients who received usual care is a limitation of the study. It
is also noted that there is a large standard deviation in urine microalbumin. The microalbumin
values are known to be actual patient results and not aberrant data entry mistakes. Hence, the
values were included in the data evaluation.
Conclusions
The persons with diabetes who were cared for in this clinic were severely obese, with
elevated HgA1C levels, nephropathy, and dyslipidemia. In addition to suboptimal physical
condition, the characteristics of persons with diabetes who receive care at this free clinic such as
multiple co-morbid conditions, less education, younger age, longer driving distances to obtain
care, Appalachian culture, and lack of health care insurance may have contributed to the lack of
improvement in biophysical outcomes of care in this population. DGMVs have been shown in
the literature to improve biophysical outcomes. However, DGMV as an intervention is not
enough to improve biophysical outcomes in this population. Interventions targeted to the unique
characteristics of this population are needed to prevent devastating complications. Such
interventions should not only cluster care, but also include improved access to care and access to
an interprofessional team. The addition of services from other disciplines such as social work or
behavioral health and the use of innovative technologies or home care services for this
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population may contribute to improved outcomes. Longitudinal studies are needed to investigate
not only biophysical outcomes of care but how improved quality of life, provider relationships,
and knowledge of disease processes could impact long-term negative consequences of diabetes.
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Appendix B: Q-Q plots Aim 4
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Appendix C: Q-Q plots for Aim 5 Usual Care
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Appendix D: Q-Q plots for Aim 5 DGMVs
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